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ABSTRACT

Persons with Type 2 diabetes (T2D) report fatigue, compromised strength and
physical performance, yet studies utilizing objective measures are sparse.

This study

assessed isometric strength, contractile properties and performance in the tibialis anterior in
6 women (50 ±5 years) and 8 men (54 ±6 years) with T2D, and 6 gender-, age- and activitymatched women (50 ±7 years) and

4 men (55 ±4 years). Muscle fatigue was examined

using a 75 % intermittent protocol. HbA1c and blood glucose were higher in T2D, but
strength, contractile properties and physical performance did not differ. Fatigue and
recovery were parallel between groups. When non-neuropathic individuals with T2D are
age, gender and activity matched to controls, they are not weaker nor fatigue faster. This
presents good news for persons who control glucose fairly well and suggests that
neuropathy, age, gender and physical activity should be considered when assessing
persons with strength and fatigue in T2D.
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GLOSSARY
Terms relating to Diabetes Mellitus
beta-cell

Pancreatic cell occurring in the Islet of Langerhans
responsible for insulin production and secretion.

cardiopathy

Disorder of the cardiovascular system; secondary
disease of Type 2 diabetes where hyperglycaemia
results in damages to the blood-carrying vessels and the
heart.

diabetes mellitus

A group of metabolic disorders characterized by
chronically elevated blood glucose.

endothelial

A single layer of cells that line blood vessels.

foot ulcer

A sore on the underside of the foot often the result of
neuropathy; when a wound goes unnoticed because of
lack of sensation and becomes severe.

galactitol

Used to artificially induce diabetes; is a chemical
origination from plants and formed by reduction of
galactose.

glucose

A monosaccharide sugar, C6H i 20 6, found in plants and
animals. Main energy source of the body.

glycosylated haemoglobin

Haemoglobin subunit (A1) that has irreversibly attached
to glucose by a glycosylation reaction. Important tool to
assess glucose control over past 120 days.

hypercholesterolemia

Excessive presence of cholesterol in blood (above 5.2
mmol/L) (Health Canada, 2007).

hyperglycaemia

High levels of glucose (beyond 3.9 - 5.8 mmol/L) in the
blood; a sign of diabetes (Health Canada, 2007).

hypertension

Abnormally elevated blood pressure [normal less than
120/80 millimetres of mercury [mmHg]; Stage 1 is 1401 5 9 /9 0 -9 9 m m Hg; S ta g e 2 is 1 6 0 -1 7 9 /1 0 0 -1 0 9 m m Hg;

Stage 3 greater than 180/110 mmHg (Health Canada,
2007)].
insulin

A protein that is produced by the beta-cells of the
pancreas important for glucose uptake into cells
(chemical ligand).

XV
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nephropathy

Degenerative disease of the kidneys; secondary disease
of Type 2 diabetes where high levels of blood glucose
results in impaired function of nephrons in the kidney.

polyol pathway

Glucose enters this cycle when aldose reductase
reduces it to sorbitol forming advanced glycation endproducts (these can cause damage to cells).

retinopathy

Degenerative disease of the retina; secondary disease of
Type 2 diabetes where increased blood glucose can
result in destruction of the retina over time.

secondary disorder

Refers to degenerative diseases of organ systems (e.g.
neuropathy) that occur as the direct result of another
condition (e.g. hyperglycaemia).

Type 2 diabetes mellitus

Non-insulin dependent form of diabetes; where insulin
recognition and receptor function is impaired resulting in
high blood glucose levels.

xvi
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II. Nerve and Muscle Physiology
action potential

Single electrical potential change occurring between the
inside and outside of a nerve or muscle fibre (originating
from the central nervous system or electrically induced).
Successive depolarization and repolarization of cell
membrane. E lectrical message.

agonist

The contracting muscle in the agonist-antagonistic pair
of opposing/working muscles.

alpha motoneurone

Neurons originating from the central nervous system,
which have axons that extend outside to control muscle
(efferent).

antagonist

Opposes the agonist in the agonist-antagonist pair; is the
muscle that lengthens.

atrophy

Wasting away, or decrease in tissue size from disease,
disuse or injury.

central activation

Reflects the ability of the central nervous system to
voluntarily initiate movement in the peripheral muscle per
demand.

central failure

Inability of the components of the central nervous system
(above the alpha motor neuron and muscle) to demand
movement from muscle.

co-activation

Activation (muscle activity) of the antagonist while the
agonist is engaged in activity.

conduction velocity

Speed of electrical message transmission (action
potential) along a nerve.

contractile properties

Refers to the electrically-induced response of a muscle.
The descriptors of that twitch are classified as contractile
properties - relating to muscle function and fibre type.

demyelination

Destruction of the myelin sheath covering nerve axons.
Interrupts signal transm ission.

dorsiflexion

An upward turning action of the foot/hand (e.. point toes
to the sky). Important component in efficient locomotion.

doublet discharge

Two action potentials that are discharged by one motor
unit close in time (less than 10 ms).

x v ii
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dynamometre

An instrument used to quantify torque production.

electromyography

The task of recording electrical activity within a muscle;
the result is an electromyograph.

electrophysiology

The study of electrical phenomena concerning bodily
function.

end-plate potential

A potential generated on the post-synaptic membrane
causing partial membrane depolarization, inducing an
action potential along the sarcolemma.

fast twitch (Type lla/llb)

A type of muscle fibre that has the ability to contract fast.
Involved in intense, short duration activity. Includes types
lia and lib.

fatigue

Defined as a decline of the force generating capacity of
muscle.

fibre type

Classification of muscle cells by function; slow-twitch (I)
and fast-twitch (lla/llb/llx).

half-relaxation time

Time it takes for peak torque to fall to one half of its
maximum value. Timing characteristic to define the
twitch.

integrated electromyography

Smoothed signal integrated over time to allow
observation of the accumulated EMG activity overtime.

inversion

To turn over or backward (e.. turn foot laterally up to
show foot underside).

isokinetic

An exercise providing variable resistance with constant
speed, with special equipment.

isometric

Muscle contraction against resistance where muscle
fibre length or joint angle does not change.

lactate

The end product of anaerobic glycolysis.

latency

T im e interval betw een stim ulus and reaction.

lateral gastrocnemius

A muscle on the posterior side of the lower leg.
Originates from the lateral and medial condyles of the
femur, inserts with the soleus muscle via the Achilles
tendon into the posterior surface of the calcaneus.
Innervated by the tibial nerve, to cause plantarflexion of
the foot.
x v iii
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maximum voluntary contraction

Greatest voluntary force generated for a muscle.

motoneurone

A neuron originating in the central nervous system or
ganglion, sends impulses to a muscle.

motor end-point

Highly innervated region of a muscle.

motor nerve

Same as motoneurone.

motor unit

A group of muscle fibres that are controlled and
innervated by a single neuron = one unit.

motor unit firing rate

Rate (number of impulses per unit of time) that a motor
unit emits action potentials.

motor unit recruitment

Important in modulation of force. Motor units of different
sizes are called upon in specific order to maximize force
production. Smallest diameter first to largest are turned
on, and largest to smallest to turn off.

motor unit remodelling

Adjacent nerve reinnervates muscle fibre when the
commanding alpha-motoneurone dies; the muscle fibre
takes on the characteristics of the adjacent nerve fibre
over time.

muscle activation

Same as activation.

muscle fibre

Muscle cell. Smallest functional unit of a muscle.

m-wave

Compound muscle action potential; the EMG result of an
electrical stimulus received in a muscle and the
synchronous action potentials from varying motor units
combine to give a general tracing.

myofibre

Muscle cell; smallest functional unit of a muscle.

myopathy

Disorder of muscle tissue.

myosin

Important contractile protein involved in cross-bridge
cycling in muscle contraction.

myosin heavy chain

C om p o n en t of myosin.

neurodegeneration

Deterioration of elements of the nervous system.

nerve

Ensheathed bundle of neurons (axons).

neuromuscular junction

Junction where alpha-motoneurone and sarcolemma
meet.
XIX
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neuron

Nerve cell. Smallest functional unit of the nervous
system.

neuropathy

Degenerative disease of the nervous system; secondary
disease occurring in type 2 diabetes from prolonged
exposure to high levels of glucose. Diagnosed clinically
by nerve conduction studies.

oscilloscope

Device used to show changes in voltage or current.

peak torque

Characteristic of the twitch; the greatest amount of force
produced from an electrical impulse elicited along a
nerve to a muscle.

peroneal nerve

Nerve innervating the tibialis anterior; derived from the
dorsal branches of the fourth and fifth lumbar and the
first and second sacral nerve. Divides into the superficial
and deep peroneal nerve.

rate coding

Refers to when the intensity of a stimulus increases the
firing rate.

reinnervation

The subsequent process by which a muscle loses nerve
stimulation and regains it, usually by adjacent nerve
input.

resting membrane potential

Charge separation established by sodium and potassium
pumps across a membrane in living cells; source of
stored or potential energy. Usually measures -70 mV.

slow twitch (Type I)

Slow oxidative; capillary, mitochondria and myoglobin
dense (red colour). More oxygen can go into it to sustain
long bouts of aerobic activity. Also denoted as Type I.

supramaximal twitch

A twitch that is elicited by incrementally increasing
voltage to obtain a maximal size twitch, then increasing
the voltage a subsequent 10 %.

surface electromyography

Type of electromyography (EMG) where signals are
collected by surface electrodes.

synaptic vesicle

In axon of neuron, carries neurotransmitters that are
stored and released at the pre-synaptic membrane into
the synaptic cleft (between pre and post membranes).

synergist

A muscle that aids the agonist in movement.

xx
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tetanus

Completely fused twitches, elicited by continuous
electrical stimulation.

tibialis anterior

Muscle that covers the tibia, originates in the lateral
surface of the tibia, inserts into the medial cuneiform and
first metatarsal of the foot; contraction will dorsiflex/
invert foot.

time to peak tension

Characteristic of a twitch, the time it takes to generate
maximal force during a twitch.

torque

Rotational force; equals force times perpendicular
distance. Units are Nm.

twitch

Muscle response to single electrical impulse, causes
change in the force tracing.

twitch interpolation

Technique that assesses whether a muscle is fully
activated. Based on the premise that if muscle is
completely engaged through voluntary effort, an
electrical impulse (makes twitch along nerve and
muscle) will not cause an increase in force.

x xi
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I. Outcome Measures
4-metre walk

Test of functional mobility; exemplifies ability to
walk/walking speed in daily living.

Activities-balance confidence
scale

Questionnaire that yields information about personal
confidence concerning balance in daily living.

activities of daily living

Daily tasks and actions that a person is or may be
involved in during a normal day that relates to their
personal autonomy.

Berg Balance Scale

Functional balance test that assesses balance
capabilities in daily living context.

D iab etes S elf-Efficacy S ca le

A clinical questionnaire assessing a person’s
perception/ability/confidence to care for his/her
diabetes.

Michigan Neuropathy Screening
Instrument

A set of questions relating to/defining the existence of
neuropathy

mobility

Ability to move safely without hindrance.

Semmes-Weinstein Monofilament

A nylon filament/bristle that bends at a predetermined
force (i.e. 10 g). Important in sensory testing of nerves.

Short-form 36

A subset of the Medical Outcomes Survey consisting
of 36 questions. It yields information relating to health
perception.

Step-test exercise prediction of
submaximal V 0 2

Submaximal predicted test of oxygen consumption
involving stepping exercise

Timed "up and go"

Test of functional mobility, gives information about
walking speed.

V 0 2 max

Maximum amount of oxygen, in millilitres [ml_], that a
person can use in one minute per kilogram of
bodyweight.

Waterloo Footedness
Questionnaire

A set of questions designed to determine leg
dominance.

Yale Physical Activity Survey

A set of questions that yield information to quantify the
amount of activity a person is involved in daily/weekly.

x x ii
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CHAPTER I
INTRODUCTION

Type 2 Diabetes Mellitus in Society

Diabetes mellitus refers to a group of metabolic disorders of the endocrine system,
where hyperglycaemia (an elevation in blood glucose concentration) is a hallmark outcome.
According to the Canadian Diabetes Association [CDA] (2003), more than two million
Canadians are affected with some form of diabetes. It has been estimated that Type 2
diabetes [T2D] (also known as non-insulin dependent diabetes mellitus) has a 90 %
prevalence rate within the general population (CDA, 2003) and traditionally the age of onset
is late adulthood. It has been suggested that changes in lifestyle and nutrition patterns,
particularly in developed nations, will largely contribute to an exponential rise in T2D (Said
& Bril, 1999). Consequent to the onset of T2D, patients often self-report muscle weakness
and reduced function (Sayer, Dennison, Syddall, Gilbody, Phillips, & Cooper, 2005). The
reduction in physical function alone causes a staggering financial burden on our health care
system (Katzmarzyk, Glendhill, & Shephard, 2000; O ’Brien, Patrick, & Caro, 2003).

Currently, there is no cure for T2D (Pontiroli, 2004), but existing treatment involves
modifications of diet,

reduction

of body fat,

exercise

prescription,

pharmaceutical

intervention and insulin therapy in some cases (Bailes, 2002). Although many components
of the aetiology of T2D have yet to be elucidated, it is believed to result from the interaction
of complex genetic and environmental factors (Ostenson, 2001). Sedentary lifestyles along
with a lack of exercise are environmental factors that are not only additive but also have the

1
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potential to influence the onset and progression of this disease when combined with
increases in adiposity and decreases in lean body mass (Skinner, 2005).

Chronic hyperglycaemia in T2D is suspected to result from insulin resistance in
hepatic, skeletal and adipose tissues and impaired insulin secretion from the beta cells of
the pancreas, or a combination of both (Silverthorn, 1998). During disease progression,
catabolic enzymes

are

subsequently

upregulated,

contributing to

increases

in fat,

carbohydrate and protein breakdown (Ostenson, 2001; Silverthorn, 1998). As a direct
result, an increase in glucose flux through metabolic pathways {i.e. sorbitol pathway) results
in impaired homeostatic function and disease progression via the excessive formation of
toxic by-products (Ivy, Zderic, & Fogt, 1999). Of particular importance to any discussion of
T2D is its constellation, metabolic syndrome. The definition of metabolic syndrome has
been redefined in recent literature as clinical perspectives and experimental ideas merge.
Although its definition is multi-factorial, the contributing elements emerge and oftentimes
contain the diagnosis of T2D. According to the International Diabetes Federation, metabolic
syndrome is defined as central (referring to girth) obesity (characterized with respect to
race) plus two of the following; elevated triglycerides, decreased FIDL (“good”) cholesterol,
increased

blood

pressure/diagnosed

hypertension,

or

increased

fasting

glucose/T2D (Zimmet, Magliano, Matsuzawa, Alberti, & Shaw, 2005).

plasma

Thus, when

assessing T2D and control subjects of similar physical attributes, care must be taken to
ensure individuals with metabolic syndrome and T2D are appropriately classified.

It is nearly impossible to tell by observation whether a person has diabetes. A person
living with abnormally high levels of blood glucose may feel “healthy” and assert “no need”

2
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to change their current lifestyle patterns because they do not experience physical signs of
their disease. This is particularly hazardous because untreated chronic hyperglycaemia has
the potential to manifest in numerous secondary disorders including retinopathy and
nephropathy, cardiopathy, neuropathy (CDA, 2003) and myopathy (Marques & Santo Neto,
2002). Although neuropathies result from other reasons, diabetes is the most common
underlying cause of disabling neuropathy (Said & Bril, 1999).

Approximately 60 % of

persons with T2D suffer from neuropathy-related conditions (Misur, Zarkovic, Barada,
Batelja, Milicevic, & Turk, 2004). Diabetic neuropathy refers to neurodegeneration resulting
from the effects of chronic hyperglycaemia and the subsequent formation of advanced
glycation end-products (King, 2001). Diabetic neuropathies are subdivided into three
categories: most commonly diagnosed are 1) distal symmetrical polyneuropathy; 2)
polyneuropathy, which occurs in two distinct forms characterized by either demyelination
(asymptomatic) and/or axonal loss (symptomatic); and 3) focal neuropathies (proximal
motor neuropathies) that occur less frequently (Brown & Asbury, 1984; Valls-Canals,
Povedano, Montero, & Pradas, 2002). In many cases, the hyperglycaemic condition that
leads to irreparable bodily damage remains undetected until physical harm occurs.

The

point where reversible damage becomes so severe that it becomes irreversible is
equivocal. Many studies have been conducted on neuropathic individuals with T2D
(Simmons & Feldman, 2002). It is important to not only focus on symptomatic individuals,
but also those who are asymptomatic for neuropathies in order to understand diabetic
disease progression.

Type 2 diabetes is projected to place an enormous economic burden on Canadian
society (O ’Brien e t a i, 2002). Hospital and physician visits, plus drug research and
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development have been estimated to pose an annual cost of 620 million Canadian dollars
(Katzmarzyk et al., 2000). Alas, the global response to the rise of chronic diseases,
including diabetes, is inadequate (Yach, Hawkes, Gould, & Hofman, 2004). To reverse
anticipated trends in world health, Yach e t al. (2004) recommend more research into
diabetes as a core task, to support policy reformation and ensure higher placement in the
government agenda to counteract economic impediments. For this reason, it is paramount
that a thorough understanding of T2D and its associated disability be established so that
appropriate interventions and treatment may be provided. Skeletal and neural tissues are
central to our ability to generate force for basic movements and locomotion. In persons
living

with

T2D,

the

neural

and

muscular

systems

are

altered

due

to

chronic

hyperglycaemia and consequent to secondary disorders. This creates extensive constraints
on performance of activities of daily living, subsequently having negative consequences on
personal autonomy and overall quality of life.

Pharmaceutical

agents

are

being

developed

to

control

and/or

mitigate

hyperglycaemia and these advances will aid in the delay and ultimately the prevention of
diabetic neuropathies. Within the realm of controlling hyperglycaemia, non-pharmaceutical
interventions such as diet and exercise adaptations are advised.

Exercise has been

prescribed as the first therapy in the management of T2D, as it improves overall physical
and mental health, decreases stress, improves immune system function, and quality of life,
as well as increasing life expectancy. When a person performs any type of exercise,
glucose is utilized as an energy source, enabling the extra to get “mopped up”. Moreover,
post-exercise glucose handling is also more efficient as free fatty acid availability is reduced
and

insulin sensitivity of glucose uptake is augmented

(Shojaee-Moradie,

4
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Baynes,

Pentecost, Bell, Thomas, Jackson e t al., 2007) from increased blood flow to the muscle,
increased capillarization, fibre type shifts from lib to lla, biochemical changes and increased
muscle mass representing acute and chronic changes (Ivy e t al., 1999). Thus, glucose
control is optimized during and following bouts of physical activity. Although exercise is
promoted as a prehabilitative and rehabilitative strategy, very little is understood about
muscle function in persons with T2D.

5
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CHAPTER II
REVIEW OF LITERATURE

Strength and Physical Function

Many people living with T2D often report muscle weakness (Andersen, Nielsen,
Mogensen,

& Jakobsen, 2004a; Andersen,

Gjerstad,

& Jakobsen, 2004b;

Cetinus,

Buyukbese, Uzel, Ekerbicer, & Karaoguz, 2005; Clarke, 2004), yet the cause of this
weakness and the influence on functional activities of daily living is presently undefined.
Possible sources of muscle weakness include neural and muscular adaptations due to
chronic hyperglycaemia, physical inactivity and/or disuse, or combinations of these factors.
The best method to study muscle function in T2D would involve longitudinal study of
persons known to be at high-risk for the development and then following diagnosis of T2D.
Due to the nature of longitudinal studies, such a study would be difficult to administer
considering issues of poor adherence that have been previously reported (Domenech,
Assad, Mazzei, Kronsbein, & Gagliardino, 1995). Given the plasticity of muscle and
differences in muscle strength due to gender (Kent-Braun, Ng, Doyle, & Towse, 2002;
Yerdelen, Uysal, Koc, & Sarica, 2006) the most appropriate, secondary method for study
involves the investigation of a group of individuals with diagnosed T2D compared to
individuals that are well matched by levels of physical activity, age and gender. This type of
matching has been utilized elsewhere (Jakobi, Killinger, Wolfe, Mahon, & Rice, 2001) and
enables scientific investigation when intervention (i.e. inducing diabetes) studies are difficult
to administer for ethical reasons or are limited by extensive ‘on-site’ involvement of clinical
staff.

6
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The final aspect of force modulation is at the level of the motor unit, through
progressive recruitment and increases in discharge rates of already active motor units
(Christie & Kamen, 2006; Kernell & Sjoholm, 1975). Such neural modulation enables the
neuromuscular system to adapt to a variety of tasks from gross movements such as
marching on the spot to more precise or fine movements such as finger-tapping. Motor unit
firing rates have been demonstrated to change during sustained isometric contractions to
maintain force (De Luca, Foley, & Erim, 1996), while recruitment of additional motor units
occur to maintain force during a submaximal fatiguing contraction (Conwit, Stashuk, Suzuki,
Lynch, Schrager, & Metter, 2000). The neural aspect of the motor unit is typically studied
with invasive indwelling EMG procedures (Connelly, Rice, Roos, & Vandervoort, 1999;
Jakobi & Cafarelli, 1998), where the contractile component can be assessed via production
of voluntary and involuntary force.

Twitch and tetanic contractile properties reflect a

muscle’s ability to generate force in time as a consequence of electrical stimulation
(McComas, 1996). In the tibialis anterior [TA] of older adults contractile properties slow and
voluntary force is reduced in older adults compared with younger adult men (Connelly e t al.,
1999). It has been suggested (Jakobi, Rice, Curtin, & Marsh, 2000) that these alterations
impair functional mobility in older adults. Functional mobility has been described as the
ability to move safely from one place to another by independent means (Shumway-Cook &
Woollacott, 2001). If contractile properties slow and voluntary force is reduced in the TA,
this would in part, explain some of the observed impairments in mobility that are directly
related to m uscle and nerve function. T o date, no study has ascertained w h eth er alterations

in contractile properties reflect the decrease in functional mobility that is self-reported by
persons with T2D in clinical histories.
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Changes in contractile properties in diabetes may be independent of age, as
hyperglycaemic

interference

in

muscle

activity

has

pharmacologically induced diabetes in rodent models.

been

reported

in

studies

of

In the murine model, there seems

to be a decrease in twitch tension, no change in contractile speed and an increase in the
synaptic delay in the flexor digitorum superficial muscle after eight weeks of induced T2D
(Fahim, El-Sabban, & Davidson, 1998). In the sternohyoid muscle of streptozotocin diabetic
rats, contraction duration [CD], half relaxation time [HRT], twitch tension and tetanic tension
increase, with no effect on fatigue and the tension-frequency relationship (McGuire,
Dumbleton, MacDermott, & Bradford, 2001), causing a net increase in the capacity for force
generation. Dietary accumulation of galactitol (a polyol pathway metabolite) induced
experimental diabetes resulted in loss of muscle mass, damage to the myofibres, slowed
time to peak tension [TPT], an increase in peak tension with no alterations in relaxation
period in the extensor digitorum longus (fast-twitch) of rats (Cameron, Cotter, Robertson, &
Cox, 1992). In the soleus muscles (slow-twitch) of these rats peak tension was unaltered,
but HRT and CD were prolonged for both a single twitch and tetanus. Interestingly, there
was a marked reduction in the number of fast oxidative glycolytic (Type lla) fibres (Cameron
et al., 1992). Overall, the results from studies of contractile alterations in animal models are
equivocal, but lend support to the notion that hyperglycaemia may alter contractile function
in humans because changes occur in rodent muscle, albeit invariably, when exposed to
hyperglycaemic conditions.

While animal studies provide interesting and valuable insight regarding physiological
mechanisms, they may not provide the most accurate description of the phenomena
involved in the development of T2D in humans. One must not only consider the biological

8

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

and species differences between animais and humans, but also the differences between
the uses of artificially induced (i.e. toxicity of drug used) versus natural diabetes (i.e.
cumulative effects of hyperglycaemia and vascular dysfunction). Caution must be followed
when utilizing the results of animal studies to understand human phenomena as it is
apparent that two entirely separate diseases are studied. Animal studies, hence, may not
completely represent the human diabetic condition due to the enormous complexity and
interplay between factors that are involved in the actual pathogenesis of diabetes.

Post-mortem study of the fibre composition of the human TA was determined to be
73 % Type I fibres and 27 % Type II fibres (Johnson, Polgar, Weightman, & Appleton,
1973). It is important to note, that fibre type composition varies between muscles and
species (Bicer & Reiser, 2004) for example, the TA in individuals with paraplegia ranges
from 1-40 % myosin heavy chain [MHC] I with MHC I la presenting as the dominant form
(32-96 %) and MHC llx in lesser amounts (<1-28 %) (Harridge, Andersen, Hartkopp, Zhou,
Biering-Sorensen, Sandri, & Kjaer, 2002), whereas the MHC composition in the TA of Fisher
rats was found to be 2.4 ± 2.1 % MHC I, 12.2 ± 6.6 % MHC lla, with dominant form MHC lib
49.0 ± 14.8 % while muscle MHC composition varied when comparing soleus, extensor
digitorum longus, superficial and deep digitorum longus muscles (Staron, Kraemer, Hikida,
Fry, Murray, & Campos, 1999). It is unknown in T2D whether changes are generally muscle
or species specific, or influenced by the agent used to induce artificial diabetes, presenting
substantial barriers in extrapolating results from anim al studies to hum ans. Although this

study will not reveal direct fibre type composition of the TA in persons with T2D, contractile
times will provide a gross measure of the general fibre type, because a relationship exists
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between fibre type and electrically induced whole muscle contractile properties (Harridge,
Bottinelli, Canepari, Pelligrino, Reggiani, Esbjornsson, & Saltin, 1996).

Muscle

volume

has

been

related

to

muscular

strength.

When

considering

neuropathic versus non-neuropathic individuals, neuropathic persons may be weaker
because of muscle loss. However, muscular atrophy alone, cannot fully explain the losses
in strength that are observed in diabetes (Lesniewski, Miller, & Armstrong, 2003) or healthy
older adults (Narici, Reeves, Morse, & Maganaris, 2004) because force decreases more
than the size of muscle (Lesniewski e t al., 2003). It has been proposed that decreases in
muscle strength may be related to alterations in the structure and function of amotoneurones (Lesniewski e t al., 2003) or incomplete reinnervation of muscle after axon
damage in a collapsed group of persons with type 1 diabetes [T1D] and T2D (Andersen,
Stalberg, Gjerstad, & Jakobsen, 1998). Following this logic, it is possible that persons with
T2D who have neuropathy could be different than persons who do not have neuropathy
because a pronounced loss of muscle mass in distal groups may be greater in neuropathic
individuals (Andersen, Gadeberg, Brock, & Jakobsen, 1997). Accordingly, Andersen et al.
(1997) suggest a length-dependent process of peripheral neurodegeneration. In individuals
with neuropathic T1D,

muscle volume and strength decrease compared to healthy

individuals and persons without neuropathic pathology; however, data of this sort are
lacking for persons with T2D (Andersen e t al., 1997). Moreover, this information has been
gained from isokinetic dyn am o m etry to assess strength of the ankle dorsal and plantar

flexors, knee extensor and flexors rather than isometric strength.

The latter enables a

direct assessment of an isolated muscle group with minimal contribution of antagonist and
synergist muscles and permit quantification of isolated whole muscle contractile properties.
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Isometric contractile properties have yet to be quantified in persons with T2D and compared
to healthy individuals.

The purpose of skeletal muscle is to produce force and necessitate movement.
Hence, muscular strength is highly related to functional ability and consequent to
weakness, declines in physical function ensue (Chandler, Duncan, Kochersberger, &
Studenski, 1998).

In older non-diabetic adults there is a strong relationship between

muscular strength in the lower limbs to gait and balance (Wolfson, Judge, Whipple, & King,
1995). As well, there is evidence to suggest that mobility, balance and endurance seem to
increase as strength is increased in older individuals (Chandler et al., 1998; Krebs, Jette, &
Assmann,

1998;

Ramsbottom,

Mulrow,

Ambler,

Gerety,

Potter,

Kanten,

Jordan,

Cornell,

Nevill,

&

DeNino,

Williams,

Chiodo
2004;

et

al.,

Toulotte,

1994;
Fabre,

Dangremont, Lensel, & Thevenon, 2003). Although data on these relationships is sparse in
persons with T2D, Brandon, Gaasch, Boyette, & Lloyd (2003) have suggested that as
strength increases, mobility improves. While losses in mobility are common in the diabetic
condition, the mechanisms contributing to the marked loss in strength and how strength
may be regained remain equivocal.

However, electromyography [EMG] data from gait

studies provide further support for altered neuromuscular function contributing to declines in
mobility in T2D. Persons with diabetic induced neuropathies required more time to develop
force during walking, and had weaker force development during braking (Meier, Desrosiers,
Bourassa,

&

Blaszczyk,

2001).

Petrofsky,

Lee,

&

Bw eir

(2004)

studied

walking

characteristics of T2D patients and noticed that persons with T2D walked slower than
controls. Persons with T2D also seemed to use a wider stance while walking in a linear
pathway and while turning indicating differences in locomotion patterns between T2D and
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controls.

This seems to be translated into gait compensatory adaptations that occur in

persons with neuropathy and T2D (Kwon, Minor, Maluf, & Mueller, 2003). During walking,
they seem to employ more co-contractions of agonist and antagonist muscles at the knees
and ankle joints during the stance phase of walking to adopt a safer and more stable
pattern of gait likely due to impaired sensory feedback (Kwon e t al., 2003). According to
Sacco & Amadio (2003), delayed EMG responses of the thigh and leg muscles during
treadmill walking suggest sensory and motor disturbances. Unfortunately, these studies did
not dissociate the T2D group into those with neuropathy and those without. Thus, it could
not be determined whether these findings were solely related to hyperglycaemia and the
diabetic condition.

Further support for alterations in neural activity of the muscle in persons with T2D
come from morphological and histological studies using rodent models. In the dorsiflexors
of the mouse, there is a decrease in resting membrane potential and miniature end-plate
potentials due to impaired sarcolemmal-Ca2+ mobilization (Fahim, Flasan, & Alshuaib,
2000), and tetanic potentiation has been found to be lower, while the neuromuscular
junction [NMJ] shows resistance to high-frequency stimulation (Schiller & Rahaminoff,
1989).

This phenomenon is suspected to result from changes in K+ gradients along the

sarcolemma after high-frequency stimulation (Schiller & Rahaminoff, 1989). As well,
ultrastructural

disruptions

such

as

reduction

in the

number

of synaptic

vesicles,

mitochondrial degen eration (F ah im et al., 1998, 2 0 0 0 ), d e cre a se s in electron-dense bodies

and myelin-like figures (Fahim e t al., 1998) with marked disarray of the microtubules and
neurofilaments of the nerves have been reported in animal models and related to the
reduction in contractile function (Fahim e t al., 2000).
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In the streptozotocin rat model, the distribution of acetylcholinesterase [AChE]
molecules in fast twitch extensor digitorum fibres is altered, resulting in a shift of the AChE
profile from fast-type to isoforms found in slow-type muscle (Kiss e t al., 2001). Such a
concentration shift was suspected to be the result of changes in neuromuscular function
(reinnervation), or from dysfunctional liberation of trophic factors (Kiss, Somogyi, Csermely,
Szelenyi, & Ver, 2001). In female diabetic mice, irregularities in acetylcholine receptors
[AChR] at the motor end-plate resulted in patchy distribution with regular junctional folds,
with co-localization of AChR and sprouts at the nerve terminal (Marques & Santo Neto,
2002). Despite the disruptions observed in the murine model, study of the rat model of
diabetes indicates that the NMJ remains intact, but intracellular myofibril disarray, myelin
figures, mitochondrial swelling and cristae lysis occur (Ozaki, Matsuura, & Narama, 2001).
As discussed earlier, the value of the experimental animal model is great for invasive study,
but the equivocal results between mouse and rat serve to highlight species differences and
the requirement for human study.

The muscle compound action potential (m-wave) is utilized to assess the integrity of
the NMJ and is a useful tool to study pathophysiology of nerves (Kim, Date, Park, Choi, &
Lee, 2005). The m-wave is induced via supramaximal electrical stimulation and results in
synchronous summation of motor unit action potentials. The amplitude of this potential is
m easured from start to p e a k and represents the tem poral and spatial sum m ation of

individual action potentials from individual muscle fibres while the duration corresponds to
the time required for the rising phase and lowering phase of the m-wave, and is determined
by temporal dispersion (Kim e t al., 2005). The overall m-wave will yield information on the
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number of functional motor units and is a useful tool to study pathophysiology of nerves
(Kim et al., 2005). Currently, no study has assessed m-waves in persons with T2D to
determine whether the NMJ is altered in humans with T2D.

Functional mobility tests enable identification of the ability to perform functional
activities including sitting and standing, but do not show the underlying mechanisms for
observed impairments in mobility. Alterations in functional mobility will have serious
ramifications on overall well-being and independence. In older persons with T2D marked
changes in postural stability and a decrease in balance occurs (Corriveau, Prince, Hebert,
RaTche, Tessier, Maheux, & Ardilouze, 2000). Such alterations in posture and balance
inevitably lead to loss of mobility which has been attributed to muscle weakness in older
persons with and without T2D. Yet, in younger persons with T2D, there is no information
available on functional mobility and muscle strength.

Leg muscles are important in

maintaining balance and posture for all upright movements. In particular, the TA is
important in dorsiflexion and inversion of the foot, which are integral components for
locomotion (Mount & Dacko, 2006). An assessment of contractile properties of the TA in
conjunction with functional mobility and balance tasks will help to understand the
relationship between changes in mobility and balance with respect to muscle characteristics
in persons with T2D.

It is quite possible that neuromuscular changes in diabetes do not happen until
advanced stages of this disease, perhaps due to chronically elevated glucose levels that
lead to secondary dysfunction (i.e. neuropathy) from ineffective disease management. Or, it
might be possible that complex changes occur in diabetes in concert with cellular processes
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that are cued during aging. This would be consistent with studies performed on older
persons with T2D who show functional changes different from healthy non-diabetic
individuals (Resnick, Stansberry, Harris, Tirivedi, Smith, Morgan e t al., 2002). Age-related
alterations in the motor unit are typically evident at approximately 65 years, but do not
manifest in functional loss of strength until 80 years or so (McNeil, Doherty, Stashuk, &
Rice, 2005). Unequivocal within the literature concerning increasing age are the noticeable
reductions in motor unit firing rates (Connelly e t al., 1999, Jakobi & Cafarelli, 1998), with a
decrease in the occurrence of motor unit doublet discharge during isometric force
production (Christie & Kamen, 2006), and an increase in discharge variability resulting in
greater fluctuations in force output in older adults (Tracy, Maluf, Stephenson, Hunter, &
Enoka, 2005). To exclude the confounding effect of age-related change on physiology of
the motor unit and its possible interplay with hyperglycaemia, middle-aged adults should be
studied.

Muscle Fatigue

Muscular fatigue involves a progressive decrease in peak tension and power output
resulting in a reduction of the overall capacity to perform muscular work (Fitts, 1996). The
aetiology involves a complicated and multi-factorial set of integrated mechanisms, some of
which have yet to be fully elucidated. When muscles fatigue in healthy individuals, timing of
the twitch profile slows and there is a decrease in the peak twitch tension (Fitts, 1994,
1996).

Disease may influence the endurance of muscle via disruptions in cellular conditions.
These changes may result in the premature development of fatigue (Westerblad &
15
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Lannergren, 2001). It is conceivable that the onset of muscle fatigue could occur earlier
because exercise in diseased conditions may begin at a point that is closer to the maximum
working capacity of the muscle (Westerblad & Lannergren, 2001). This may be particularly
true concerning the altered metabolic state of tissues due to hyperglycaemia. If this is a
valid conjecture, an experimental fatigue protocol must ensure that all subjects work at the
same relative intensity. In older adults the time to fatigue is longer than younger individuals
when both groups perform at the same intensity for both isometric and dynamic tasks
(Lanza, Russ, & Kent-Braun, 2004). It is unknown how persons with T2D will respond to the
same work intensity.

It is important to make note of the potential influence of metabolic status on
motoneurone activation state and muscle fatigue (Duchateau, Balestra, Carpentier, &
Hainaut, 2002). Impaired glucose metabolism will influence aerobic fatigue, due to the
altered metabolic energy supply. To minimize differences due to glucose metabolism, an
anaerobic submaximal intermittent fatigue protocol would be optimal. To monitor metabolic
status, blood glucose should be measured prior to and after the fatigue protocol to observe
the glycaemic response to exercise. As well, lactate is a by-product of anaerobic energy
production. During exhaustive exercise, lactate is produced and accumulates within the
tissues leading to its subsequent diffusion into the venous supply. Measures of blood
lactate and glucose would yield a gross representation of the metabolic status of the tissue,
and has yet to be measured in persons with T2D.

In older persons, motor unit remodelling is believed to occur and has been related to
the selective atrophy of fast-twitch fibres allowing slow twitch fibres to predominate in a
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muscle (Macaluso & De Vito, 2004).

Interestingly, while maximal muscle strength

decreases during the aging process, muscular endurance is preserved. This “fatigue
paradox” has been described as task-dependent which varies among muscle groups
(Allman, Cheng, & Rice, 2004; Lanza e t al., 2004) and is likely due to age-related motor unit
remodelling (Lanza e t al., 2004, Macaluso & De Vito, 2004). The ankle dorsiflexors in older
persons for an isometric submaximal endurance test are more fatigue resistant (Lanza et
al,, 2004). Since time to fatigue depends on a person’s fitness level (Garland, Walton, &
Ivanova, 2003) and fibre type composition (Hamada, Sale, MacDougall, & Tarnopolsky,

2003), there is reason to believe that the occurrence of fatigue may be different in persons
with T2D. Furthermore, it remains unknown whether contractile properties are altered
during fatigue in individuals with T2D, and whether the magnitude of change reflects the
state of diabetic condition (i.e. glucose levels).

To date no study has assessed muscle

endurance in a controlled task in persons with T2D.

Prior study of Addison’s Disease, an

endocrine disorder of the adrenal gland, has suggested that patients’ self-report of muscle
weakness and fatigue are not measured as changes in endurance time, or contractile
function in controlled laboratory studies (Jakobi e t al., 2001).

Whereas, in studies of

chronic fatigue syndrome (Lloyd, Gandevia, & Hales, 1991), poliomyelitis (Allen, Gandevia,
Neering, Hickie, Jones, & Middleton, 1994) and fibromyalgia (Miller, Allen, & Gandevia,
1996) decreases in muscle endurance have been related to alterations in contractile
function.
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Objectives

The relationship between functional mobility and neuromuscular properties has yet to
be determined in T2D. Also, little is known whether differences exist in muscle fatigue
between non-neuropathic persons with T2D and healthy individuals. Neuromuscular studies
are essential, as the design and execution of effective therapeutic intervention cannot be
successful without a thorough understanding of the neuromuscular adaptations to disease.

The overall objective of this thesis is to characterize neuromuscular properties,
functional mobility, balance and fatigue in middle-aged persons with T2D.

S p e c ific G o a ls

A im 1: To determine whether strength, m-wave and twitch contractile properties of
the TA are different between persons with non-neuropathic T2D from age, gender
and activity-matched individuals.

A im 2: To study the relationship between neuromuscular properties, balance and
functional mobility in persons with non-neuropathic T2D.

A im 3: To investigate acute fatigue and recovery of the TA in persons with nonneuropathic T2D.
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CHAPTER III
DESIGN AND METHODOLOGY

Subjects and Recruitment

Prior to participation in this study, all subjects provided written informed consent.
This investigation was conducted in the Neuromuscular Laboratory at the University of
Windsor in accordance with the Declaration of Helsinki (The World Medical Association
General Assembly, 2004) and the guidelines established by the University of Windsor
Human

Research

Ethics

Board

(Appendix

A).

Volunteers

were

recruited

through

advertisements in local pharmacies, the University of Windsor Cardiac Rehabilitation
Program, the St. Denis Centre (fitness centre), advertisements in local newspapers, and
mass campus email (Table 1; Appendix B). All procedures were thoroughly explained by
the investigator prior to obtaining consent (Appendix A).

S u b je c t In c lu s io n C rite ria . Volunteers were able to walk independently without pain or
assistive devices, free from orthopaedic, neurological or mental disorders, were not
pregnant, of sound general health, and demonstrated a willingness to participate in this
study to be included. D ia b e te s G roup. All persons with diagnosed T2D completed
glycosylated haemoglobin [HbA1c] testing in the lab (A1c Now Multi-test System, Metrika
Inc., Sunnyvale, CA) as a screening test to indicate glucose control over the past 120 days
(HbA1c less than 8 % is considered optimal) (Appendix C). HbA1c is considered a useful
tool for diabetes management, and diabetes-risk screening (Edelman, Olsen, Dudley,
Harris, & Oddone, 2004). C o n tro l G roup. All matched individuals for control were free from
a history of diabetes mellitus (according to subject reported information from their personal
19
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physician), and also underwent HbA1c testing to ensure no chronic elevations in blood
glucose over the past three months (excluded if HbA1c >7 %).

All controls were age,

gender and activity matched to persons with T2D.
S u b je c t E x c lu s io n C rite ria . Volunteers were excluded if they had serious musculoskeletal
disorders, injury, neurological diseases unrelated to diabetes, severe cardiovascular
disease or history of heart attack, electrical implants (i.e. cardiac pacemaker), recovering
from surgery, acute focal neuropathy and acute painful neuropathies (Braune, 1997),
myopathies

(Braune,

1997;

Roos,

Rice,

Connelly,

& Vandervoort,

1999),

bilateral

orthopaedic pathologies of the lower limbs (Roos et al., 1999), lower extremity dysfunctions
or extreme physical activity patterns.

Table 1. A list of recruitment tactics showing the number of attempts made, estimated
contact and the total number of persons recruited with T2D from July 2005 to June 2006.

Recruitment Strategy
Posters
Windsor Star Saturday

Attempts Made

Distribution Rate

Responses

-7 5

Not applicable [n/a]

5

1

207,163

5

1

4,000

1

2

2,339

1

-1 3

n/a

0

n/a

n/a

6

Edition News
University of Windsor
DailyNews
Campus mass email to
Faculty/Staff
Diabetes educator
groups
Word of Mouth
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Session One: Experimental Protocol and Arrangement

L a b o ra to ry F a m ilia riz a tio n . Subject familiarization with the study and experimenters
occurred on the first visit to the laboratory. During this visit, subjects were asked to
complete consent forms, background questionnaires, physical performance tests and
sensory testing.

Q u e stio n n a ire s . Subject Contact Sheet (Appendix C) and Background Questionnaire
(Appendix C) were used to collect general personal and contact information. The YPAS
was administered in order to assess physical activity patterns and for subject matching
(DiPietro, Caspersen, Ostfeld, & Nadel, 1993) (Appendix C) and the Waterloo Footedness
Questionnaire [WFQ] (Elias, Bryden, & Bulman-Fleming, 1998) (Appendix C) was used to
determine leg dominance. The RAND 36-item Health Survey 1.0 [SF-36] (Appendix C) was
utilized to assess physical functioning, bodily pain, role limitations from health problems,
and role limitations from emotional or personal issues, emotional well-being, social
functioning, energy/fatigue and perception of general health. The Diabetes Self-Efficacy
Scale [DSES] (Appendix C) was employed to yield information about personal confidence
with respect to living and caring for their diabetes. The Activities-specific Balance and
Confidence scale [ABC scale] (Powell & Myers, 1995) (Appendix C) assessed balance
confidence while performing daily activities.

P h y s ic a l P e rfo rm a n c e Tests. To quantify functional mobility and balance, a series of
simple physical performance tests were utilized including the Berg Balance Scale [BBS]
(Appendix D) to measure balance capability, Timed “up and go” test [TUG] (Podsiadlo &
Richardson, 1991) (Appendix D) and the 4-metre timed walk [4m walk] (Guralnik, Fried,
21
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Simonsick, Kasper, Lafferty, 1995) (Appendix D) to assess walking speed and the Step
Test Exercise Prediction [STEP] to obtain information about heart rate responses to
exercise, and to estimate submaximal oxygen uptake (Petrella, Koval, Cunningham, &
Paterson, 2001) (Appendix D).

S c re e n in g fo r D ia b e tic N e u ro p a th y . Screening for diabetic peripheral neuropathy was
conducted by sensory testing using a 10-gram [g] Semmes-Weinstein monofilament
(Neuropen, Owen Mumford Ltd., Brook Hill, Woodstock, UK) by application to the dorsum of
the great toe between the interphalangeal joint and cuticle of the nail using brief (1 second
[s]) vertical, even pressure. The subjects were blinded and asked to respond to whether
they felt the pressure by saying “yes”. This test was repeated 10 times with a + 8/10
response as no indication of neuropathy or a 0-7 positive indication of neuropathy (Padua,
Saponara, Ghirlanda, Aprile, Padua, Pauri et al., 2001) (Appendix C). The Michigan
Neuropathy Screening Instrument [MNSI] (Appendix C) was used in conjunction with the
aforementioned

sensory testing to confirm the existence of peripheral

neuropathy

(Feldman, Stevens, Thomas, Brown, Canal, & Greene, 1994). Control subjects were also
tested to maintain consistency between groups and to assess non-diabetic related sensory
abnormalities

Session Two: Experimental Protocol and Arrangement

E x p e rim e n ta l A rra n g e m e n t Measures of contractile function and muscle endurance
occurred during the second visit to the laboratory. To reduce the potential ergogenic effects
of caffeine on the generation of peak force and muscle fatigue, the subjects were asked to
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abstain from consumption of caffeine for at least 2 hours prior to the second session of the
study (Kalmar & Cafarelli, 1999). All tests were performed on the TA of the non-dominant
leg except in three instances where knee impairment (n=2) or previous muscle injury (n=1)
prevented study of the non-dominant leg. The subject was seated in a custom-built
isometric dynamometer with the ankle of the non-dominant leg positioned to 30° of plantar
flexion, and the hip and knee joints positioned at 90°. To minimize hip flexion, a seat-belt
was utilized to maintain seated position during dorsiflexion. A series of two straps were
used to restrict movement at the region of the dynamometer footplate during isometric
contractions. Force measurements were collected by a commercial load cell attached to the
underside of a metal footplate (Model MLP-500-T, Transducer Techniques, Inc., Temecula,
CA). Signals were amplified and filtered (60-Hertz [Hz] notch filter), sampled at 1000 Hz
(Model V72-25A, Coulbourn Instruments, Allentown, PA) and displayed on an oscilloscope
in real-time for the subject to observe during the study session for feedback of their
movements. Signals from the load cell were subsequently converted from analog to digital
format using a 12-bit analog to digital [A/D] converter (Model 1401, Cambridge Electronic
Design, Ltd., Science Park, Cambridge, UK) and displayed on a computer monitor. Offline
quantification was completed using Spike 2 version 5 (Cambridge Electronic Design, Ltd.,
Science Park, Cambridge, UK). The load cell was calibrated with known weights to confirm
consistent linear recordings over trials.

Surface Electrom yography. S urface electrom yography [sE M G ] signals of the T A and
lateral gastrocnemius [LG] were obtained using self-adhering, disposable electrodes (4
millimetres [mm]). The TA ground electrode was positioned over the patella, while the
reference electrode was placed over the distal tendon of the TA. The active electrode was
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then positioned 1 centimetre [cm] distal to the motor end point of the TA. The motor end
point was located using continuous single pulses (100

microsecond [ps] single square

waves) by applying increasing current to the surface over the TA until an obvious response
or muscle twitch was noted. To record co-activation of the antagonist LG muscle, the
ground electrode was placed over the patella, while the active electrodes were placed 1
centimetre [cm] apart over the mid belly of the LG. Surface electromyography signals were
amplified (1.0 Hz) and filtered (13-1000 Hz) (Model V75-04, Coulbourn Instruments,
Allentown, PA) and converted from analog to digital by a 12-bit A/D converter (Model 1401,
Cambridge Electronic Design, Ltd., Science Park, Cambridge, UK) and displayed on a
computer monitor. Offline quantification was completed using Spike 2 version 5.

T w itch C o n tra c tile P ro p e rtie s . Contractile properties were elicited percutaneously using
an electrical stimulator (Model DS7AH, Digitimer Ltd., Welwyn Garden City, Hertfordshire,
UK) and a hand-held custom made electrode bar (4 cm length). The peroneal nerve was
palpated along the lateral side of the tibial tuberosity of the non-dominant leg. Contractile
properties were measured by evoking single twitches at a frequency of 1 Hz with a pulse
duration of 100 ps.

Stimulation intensity was determined by increasing current intensity

until a plateau of m-wave was observed (Figure 1). The stimulation current was then
increased 10 % to ensure supramaximal twitch responses. Force and sEMG signals were
monitored on a computer screen during each session and quantified offline. Measurements
of electrically-induced contractile properties consisted of: p e ak twitch torque [PT], TPT and
HRT (Figure 2).

PT, TPT, and HRT were obtained from the average of 8-12 twitch force

profiles. M-wave characteristics assessed were latency, motor nerve conduction velocity,
and peak to peak amplitude. Latency was measured from the end of the stimulus artefact to
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the rising phase of the m-wave. Motor nerve conduction velocity was calculated using the
distance from the centre of the stimulating electrode to the active recording electrode in
metres [m] divided by the latency (in seconds) (Figure 3).

M-wave latency, conduction

velocity and peak to peak amplitude data were calculated from the average of 8 - 1 2 muscle
compound action potentials.
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Figure 1. M-wave and twitch growth following successive stimulation of the tibialis anterior.
The top portion of the graph shows the incremental growth and subsequent plateau of the
m-wave, while the bottom portion shows twitch growth and plateau.
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Time to Peak Torque (TPT)
P e a k T o r q u e (PT)

Half Relaxation Time (HRT)

Time (ms)

Figure 2. A single twitch showing Pt (Newton-metre [Nm]), TPT (milliseconds [ms]) and
HRT (ms).
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Onset of la ten cy; End of latency
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>
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Figure 3. A single m-wave showing latency (ms) and peak to peak amplitude (V)

M a xim u m

V o lu n ta ry C o n tra c tio n a n d T w itc h In te rp o la tio n .

To assess isometric

voluntary strength subjects were instructed to force their toes upwards as hard and as fast
as possible (dorsiflexion of the tibialis anterior) and maintain the position for 5 s while
26
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provided with visual feedback from an oscilloscope and strong verbal encouragement
(maximum voluntary contraction, [MVC]). To familiarize subjects with this effort three MVCs
were performed prior to testing. Subsequently, the interpolated twitch technique was utilized
to assess central drive to the TA, where the presence of a superimposed twitch on the force
record indicates a lack of motivation or central failure. This technique involves application
of a maximal electrical stimulus over the surface of the peroneal nerve prior to, during and
after an MVC (Figure 4). This measure was calculated as the torque amplitude from the
superimposed twitches (Ts) compared with a resting twitch (Tr) obtained after the MVC trial:

% Muscle Activation = [1- (Ts/T r)] x 100

Rest

(A)

3 second contraction
= electrical impulse

5 minute rest

Time (s)

Figure 4. An MVC effort showing twitch interpolation at positions 1 (reference twitch), 2 and
3 (supramaximal twitches) and 4 (resting post-twitch).
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Three MVCs separated by approximately 3 minutes of rest were performed. Force and
sEMG signals were monitored on a computer screen during each session and quantified
offline. The peak force generated during each MVC trial, in addition to the corresponding
muscle activation was calculated and the best attempt was used as the MVC.

F a tig u e Task. Blood glucose and blood lactate were measured before and at the end of the
fatigue protocol as a gross indication of metabolic activity using a blood glucose monitoring
system (Appendix C) (Ascencia Contour 7152, Bayer Healthcare LLC, Mishawaka, IN) and
a standard blood lactate test metre (Appendix C) (Lactate Pro, Arkray Factory, Inc., KoukaGun, Shiga, Japan). The 75 % submaximal intermittent fatigue test was administered via,
the subject being instructed with the use of prompts from an oscilloscope to exert a given
muscle force with a work to rest ratio of 6 to 4 s, respectively. The protocol involved five, 75
% MVC efforts and one MVC every minute [min] until the end task criterion was met (MVC
force decreased to 75 % of muscle force). Consistent, strong verbal encouragement from
the experimenter and visual feedback from an oscilloscope were provided to each subject
during the fatigue task. The stimulation intensity utilized for the fatigue protocol was the
level of optimal tetanic force production.

Fused tetanic contractions were obtained by

sequentially increasing current intensity and ensuring voltage compliance (200-300 ms) to
obtain fused tetanus by delivering a burst of 16-50 ps wide pulses at a rate of one pulse
every 20 ms (50-Hz).

The tetanic contraction occurred once per each minute cycle.

C entral drive w as a ssessed using the m odified twitch interpolation technique (Connelly et

al., 1999), and muscle activity was assessed with sEMG. Electrically-induced contractile
properties were obtained from single and double pulses administered at pre-determined
times throughout the protocol (Figure 5).
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Electfic.il event

Single pulse

Double pulse

One-Minute Cycle

Figure 5. A 75 % submaximal, modified Bigland-Ritchie fatigue protocol showing regions of
stimulation and pulse numbers over a one minute cycle. The cycle was repeated until the
target MVC (shown in black) becomes 75 % of the original force produced in the pre-fatigue
condition. Submaximal 75 % MVC target efforts are shown as grey shaded blocks.

R e c o v e ry

fro m

F a tig u e .

Muscle

recovery

was

assessed

with

electrically-induced

contractile properties, central activation, force and sEMG at 1, 3, 5 and 10 minutes after
fatigue was declared. Each subject was instructed to perform a single 75 % contraction,
MVC and 75 % contraction for 6 s with 4 s of rest separating each contraction (Figure 6).
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Electrical event

Single pulse

«-------------

30-second cycle ----------------- ►

Figure 6. Depiction of the recovery cycle performed at 1, 3, 5, and 10 minutes post-fatigue.
Solid black box represents a 100 %MVC target force, while shaded boxes represent 75 %
target force.

D ata A n a ly s is . Time to fatigue was noted as the number of fatigue cycles completed until
the end-task criterion was obtained (MVC reached 75 %MVC force). Force and sEMG
signals were monitored on a computer screen during each session and quantified offline.
The peak force generated during each MVC per cycle, in addition to the corresponding
muscle activation was calculated and normalized to the first MVC (100 %). Twitch PT, HRT
and TPT were normalized to the pre-fatigue values.

Surface electromyography signals

were full-wave rectified and integrated [iEMG] over 0.5 s intervals for the middle 2 s of the
M V C and first 7 5 % effort after the M V C in each cycle of fatigue and recovery. T h e M V C

and 75 % iEMG for each cycle were normalized to the first MVC performed in the fatigue
task .
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Statistical Methods

Independent t-tests were utilized to determine differences between persons with
Type 2 diabetes and matched controls with respect to the dependent variables of
anthropometry (age, weight, waist to hip ratio), activity scores (YPAS), balance confidence
(ABC Scale Score, %), balance ability (BBS, out of 56), self-perceived health status,
diabetic neuropathy (Monofilament test, out of 10; MNSI, out of 15), walking ability (TUG
score, 4m walk score, S P W T score), exercise score (STEP score), HbA1c (%), blood
glucose (millimoles per litre, [mmol/L]) and lactate (mmol/L). As well t-tests were conducted
on baseline measures of twitch contractile properties at baseline (PT, TPT, HRT), MVC,
central activation and m-wave measures (latency, conduction velocity, peak to peak
amplitude).

Dependent variables of contractile properties, force, central drive and iEMG from the
fatigue task were compared between T2D and controls with two-way (2 groups x 7 levels)
analysis of variance [ANOVA] tests. Comparisons were made for the start, middle, and end
of fatigue and at 1, 3, 5 and 10 minutes post fatigue.

Linear regression analysis was conducted to determine the strength of the

relationship between resting blood glucose and HbA1c, HbA1c and conduction velocity, PT
com pared to T U G score and fast p ace S T E P predicted V 0 2 m ax com pared to M V C scores

in persons with T2D and healthy individuals.
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CHAPTER IV
ANALYSIS OF RESULTS

Physical Performance and Health Related Questionnaires

Six women (50 ± 5 years) and 8 men (54 ± 6 years) with diagnosed T2D, as well as
a group of healthy age, gender and activity matched women (6; 50 ± 7 years) and men (4;
55 ± 4 years) served as control in this study. Age, weight, height and waist to hip ratio were
similar between T2D and control (Table 2). Persons with T2D had significantly higher blood
glucose (8.33 ± 2.21 mmol//L, P=0.001) and HbA1c (8.4 ± 1.3 %, P= 0.00002) levels
compared with the control group (5.50 ± 0.95mmol/L; 6.1 ± 0.4 %). Persons participating in
this study were living with diagnosed T2D ~5.2 ± 4.4 years. Only one participant (living with
T2D) was a smoker. Ninety-three percent of the diabetic persons considered themselves as
overweight, whereas all of the controls believed they were overweight. Physician diagnosed
hypertension (43 %) and hypercholesterolemia (71 %) were prominent in T2D. However, in
the controls 20 % reported hypertension and hypercholesterolemia. There were no reports
or indication of foot ulceration at the time of the study, and 86 % of the T2D subjects
reported a next of kin (parent, grandparent, and sibling) history of diabetes. Sixty-four
percent of T2D subjects reported metformin as the primary method of glucose control while
21 % used insulin, and 14 % utilized dietary modifications (Table 2).
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Table 2. Anthropometric data of subjects with T2D and control individuals. Values are
represented as mean ± standard deviation.

Characteristic

T2D

Control

P value

52.6 ± 6 .2

51.7 ± 6 .9

0.73

Weight (kilogram [kg])

102.0 ± 18.6

99.2 ± 18.7

0.72

Height (cm)

172.6 ± 12.0

170.4 ± 6 .3

0.60

Waist to Hip Ratio

0.94 ± 0.09

0.92 ± 0 .0 7

0.47

Glucose (mmol/L)

8.33 ±2 .2 1

5.50 ± 0 .9 5

0.001

HbA1c (%)

8.4 ± 1.3

6.1 ± 0 .4

0.00002

Years since diagnosis

5.2 ± 4 .4

n/a

n/a

n=1

n=0

n/a

n=13
n=0
n=1

n=10
n=0
n=0

n/a

n=6

n=2

n/a

n=10

n=2

n/a

n=0

n=0

n/a

n=1

n/a

n/a

n/a

Age (years)

Smoker
Weight perception
Overweight
Underweight
Healthy Weight
Hypertension (physician diagnosed)
Hypercholesterolemia (physician diagnosed)
Foot Ulcers

CM

n
c

Family History of T2D (next of kin)
Primary medications for T2D control
Metformin
Insulin
Diet

n=9
n=3
n=2
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Blood glucose had a weak negative relationship to conduction velocity (Figure 7)
while HbA1c was not related to conduction velocity (Figure 8). Blood glucose and HbA1
showed a good positive relationship (Figure 9).
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Figure 7. The relationship between conduction velocity and resting blood glucose.
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The control and diabetes groups were similar in total weekly energy expenditure
(P=0.37), number of hours of daily activities performed (P=0.45), number of flights of stairs
climbed (P=0.43) and average walking speed (P=0.37). Stair climbing time from the STEP
exercise test was similar between groups (P=0.93) and the resting heart rate and post heart
rate response for the normal (P=0.73) and fast (P=0.40) stepping task did not differ (Table
3). In both groups heart rate increased significantly from rest for the normal and fast paced
exercise tasks (T2D normal p=7.5 x 10'11, fast p=7.5 x 10"10; Control normal p=7.9 x 10"5,
fast p=5.4 x 10"4) indicating the cardiovascular system was challenged.

Persons with diabetes had significantly lower (P=0.03) functional balance scores
(53.1 ± 1.8) compared with the controls (54.6 ± 1.1), yet the perception of personal
confidence in balancing (ABC scale) was similar between groups. Even though the people
with T2D showed no difference in the majority of the performance tests, data from the SF36 showed that they perceived their health to be worse than controls in terms of how their
emotional and physical health have affected their social roles (family, work, friends).
Overall, persons with diabetes had poorer scores reflective of their emotional and general
health (Table 4). On a 10 point scale, persons with T2D scored 7.0 ± 2.4 for the D S E S ,
which measures confidence with respect to the education they received from clinicians and
educators in caring for their health (Table 4). Both T2D subjects and controls received low
neuropathy screening scores, indicating an unlikely presence of neuropathy (M N S I) or

neuropathy of the peroneal nerve (monofilament score) (Table 4).
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Table 3. Functional mobility, balance and daily activity scores. Values are represented as
mean ± standard deviation.

Measure

T2D

Control

P value

9098.6 ± 10101.2

6113.6 ±2313.4

0.37

Activity Score (hours/week)

37.6 ± 41.2

27.2 ± 10.1

0.45

Number of Flights Climbed

8.7 ± 6 .2

6.7 ± 5 .4

0.43

Resting heart rate (BPM)

73.0 ± 9 .3

72.6 ± 11.7

0.93

TUG (s)

9.6 ±2.1

8.9 ± 1.3

0.37

53.1 ± 1.8

54.6 ± 1.1

0.03

84.0 ± 14.0
59.0 ±10.8

80.4 ± 2 8 .8
54.5 ±12.7

0.69
0.42

118.1 ± 13.7
127.9 ± 16.6

120.5 ± 18.8
135.7 ± 23.3

0.73
0.40

25.3 ±4. 4
30.9 ±5. 0

27.3 ±6.1
33.2 ± 2. 4

0.37
0.27

Energy Expenditure (kcal/week)

Berg Balance Scale (/56)
Stair Time (s)
Normal Pace
Fast Pace
Post-Exercise HR (BPM)
Normal Pace
Fast Pace
Predicted Submaximal VO2
(mL/kg/min)
Normal Pace
Fast Pace
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Table 4. Health related questionnaire scores. Values are represented as mean ± standard
deviation.

Measure

T2D

Control

P value

88.2 ± 15.2

89.5 ± 13.0

0.83

Emotional problems

69.0 ± 4 0 .2

100 ± 0

0.02

Physical Health

54.8 ± 4 1 .6

92.5 ± 16.9

0.01

Emotional Well-being

74.6 ± 2 1 .0

91.2 ± 5 .9

0.02

General Health

53.2 ± 18.5

76.5 ± 16.5

0.004

DSES

7.0 ± 2 .4

n/a

n/a

MNSI (/15)

4.5 ± 1.7

4.1 ±2 .1

0.62

Monofilament Score (/10)

9.8 ± 0 .4

9.9 ± 0 .1 7

0.21

ABC Scale Score
SF-36 (%): Role Limitations

SF-36 (%)

Isometric Muscle Strength: Voluntary and Involuntary Components

Twitch contractile properties and muscle strength were similar between persons with
T2D and controls and both groups were equally able to activate the TA muscle (Table 5).
M-wave latency, conduction velocity and peak to peak amplitude were similar between
groups, indicating no change in peroneal nerve function or alterations in contractile
properties as a result of hyperglycaemia for these persons with T 2 D com pared to controls
(Table 5).
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Table 5. Voluntary and involuntary force results for persons with T2D compared to matched
controls. Values are represented as mean ± standard deviation.

T2D

Control

P value

4.1 ± 1.5

3.9 ± 1.3

0.66

Time to Peak Torque (ms)

94.8 ± 11.3

100.3 ± 13.0

0.36

Half-relaxation time (ms)

114.5 ± 2 2 .9

105.8 ± 2 0 .0

0.49

0.003 ±0.001

0.002 ± 0.001

0.08

63.1 ± 17.5

73.6 ± 14.9

0.14

1.7 ± 2 .0

0.85 ± 0 .2 4

0.20

39.6 ± 9 .6

34.3 ± 7.6

0.19

98.8 ± 3.4

100.0 ± 0

0.26

0.11 ± 0 .0 3

0.12 ± 0 .0 4

0.43

Measure
Twitch Contractile Properties
Peak Torque (Nm)

M-wave
Latency (ms)
Conduction Velocity (m/s)
Peak to Peak Amplitude (V)
MVC
Peak Torque (Nm)
Central Activation (%)
Twitch: MVC ratio (Torque)

A series of regressions were completed between functional mobility scores (BBS,
TUG, STEP) compared to MVC strength and PT. TUG scores and PT showed a positive
relationship in control (R2=0.6964) but not T2D (R2=0.011) groups (Figure 10). As well,
STEP Predicted Submaximal V 02 (fast pace) and MVC showed a negative relationship in
control (R2=0.6745) but not in T2D (R2=0.0081) groups (Figure 11).
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Muscle Fatigue

Pre-exercise glucose (8.3 ± 2.2; 5.5 ± 0.9 mmol/L) and post exercise glucose levels
(7.7 ± 2.0; 5.2 ± 0.9 mmol/L) were significantly different (P=0.001; P=0.001) between T2D
and controls, albeit the magnitude of the increase in blood glucose was similar between
groups (P=0.72). Pre-exercise blood lactate (3.8 ±5. 1; 2.2 ± 1.1 mmol/L) and post-exercise
blood lactate (4.6 ± 5.3; 2.2 ± 1.3 mmol/L) did not differ between groups (P=0.33; P=0.16),
and increased in the T2D group but not in the control group after the fatigue task. The
magnitude of change in blood lactate was not different between groups (P=0.72) (Table 6).

Table 6. Submaximal fatigue time to failure and gross estimates of metabolic change. Each
value represents the mean plus standard error bars.

T2D

Control

P value

4.9 ± 2 . 5

7.9 ±5. 1

0.07

Pre-exercise

8.3 ± 2 . 2

5.5 ± 0 . 9

0.001

Post-exercise

7.7 ± 2 . 0

5.2 ± 0 . 9

0.001

0.61 ± 0 . 8 8

0.27 ± 0.72

0.31

Pre-exercise

3.8 ±5. 1

2.2 ± 1.1

0.33

Post-exercise

4.6 ± 5.3

2.2 ± 1.3

0.16

0.78 ± 7 . 1 4

0.01 ± 1.03

0.72

Measure
Fatigue Time (minutes)
Blood Glucose (mmol/L)

Total change (decrease)
Blood Lactate (mmol/L)

Total change (increase)
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Time to fatigue ranged 2 - 1 1
(Figure 12).

minutes for T2D, and 3 - 2 0

minutes for controls

The average duration of the fatigue task was slightly longer in the control

group (p=0.07) (7.9 ±5. 1 minutes) compared with T2D (4.9 ± 2.5 minutes) (Table 6).

Control
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Figure 12.

MVC force achieved during the fatigue exercise over time, expressed as a

percentage of the pre-fatigue MVC. Performance of persons with T2D is shown as solid
lines and control group as dotted lines.

Central activation did not differ between groups, and was near maximal for the
duration of the fatigue protocol (Figure 13). Although force decreased significantly by the
middle of the fatigue task (85 %) and slightly more by the end of the task (77 %) it was
similar between groups. Force did not recover in either group to the pre-fatigue values 10
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minutes after the exercise bout (Figure 13).
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Figure 13.

MVC performance and muscle activation (central drive) over time during the

fatigue and recovery tasks. The MVC force (Nm), was normalized to the MVC obtained
prior to fatigue and expressed on a time scale as start or pre- (0), middle (50) and end
(100). The recovery phase is shown in minutes at 1 (R1), 3 (R3), 5 (R5) and 10 (R10)
minutes post-fatigue declaration. Each value represents the mean plus standard error bars.
The top lines represent central drive while the bottom lines represent the normalized MVC
force (* represents a statistically significant difference from pre-fatigue, where P<0.05).

Peak torque was significantly different from pre-fatigue at the middle and end, and
declined to approximately 58 % midway through the fatigue task (P<0.05), although it did
not fall significantly between the middle to the end of the fatigue task. At 10 minutes post-
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fatigue, there was a significant recovery of twitch PT to approximately 75 % of the pre
fatigue value (Figure 14).
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Figure 14. Single twitch peak torque (Nm) performance during fatigue and recovery for the
T2D and control groups during the fatigue and recovery tasks. All Pt values obtained were
normalized to the pre-fatigue peak torque. Each value represents the mean plus standard
error bars.

*lndicates significant difference from pre-fatigue.T2D differed from controls

significantly along the fatigue and recovery tasks.

Over the duration of the fatigue task contractile properties did not slow.

TPT was

similar between groups for the fatigue and recovery tasks. At 5 and 10 minutes post-fatigue,
TPT was significantly shorter than the pre-fatigue value (approximately 88 and 85 %, for 5
and 10 minutes, P>0.05) (Figure 15). HRT was similar between groups during the fatigue
and recovery task (Figure 16).
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Figure 15. Single twitch time to peak torque (ms) values for the T2D and control groups
during the fatigue and recovery tasks. All TP T values obtained were normalized to the pre
fatigue

peak torque.
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value

represents the

mean

plus standard

* Represents significant difference (P<0.05) from pre-fatigue value.
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error bars.
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Figure 16. Single twitch half-relaxation time (ms) values for the T2D and control groups
during the fatigue and recovery tasks. All HRT values obtained were normalized to the pre
fatigue

peak torque.

Each

value

represents the

mean

plus standard

error bars.

* Represents significant difference (P<0.05) from pre-fatigue value.

Integrated electromyography was similar between the T2D and control groups.
Submaximal iEMG increased significantly during the fatigue protocol and remained
elevated from pre-fatigue values for the 10 minutes of recovery. Maximal iEMG was similar
between groups and did not change for the fatigue task, yet there was a slight decline in
both groups during recovery (Figure 17).
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Figure 17.

IEMG expressed as a percentage of the pre-fatigue MVC. The top lines

represent the iEMG obtained for the 100 % MVC performance during the fatigue and
recovery protocol and the bottom lines represent the 75 % MVC iEMG normalized to the
pre-fatigue MVC iEMG. Each value represents the mean plus standard error bars.
* Represents significant difference (P<0.05) from pre-fatigue value.
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CHAPTER V
DISCUSSION
Subjects and Recruitment

This is the first case-control investigation to measure isometric contractile properties
and relate muscle strength and contractile activity to functional mobility in persons with
T2D. In addition to characterization of the above mentioned properties in persons with T2D,
the specific objectives of this study were to compare these findings to a control group of
non-diabetic persons who were matched for both physical attributes and physical activity
levels. Age, gender, body size and physical activity are strong factors in functional mobility
and strength (Kent-Braun et al., 2002; Wolfson e t al., 1995; Yerdelen e t al., 2006), yet very
few studies match for age and gender (Corriveau et al., 2000; Meier e t al., 2001) and no
study of persons with T2D has considered physical activity a key factor in muscle
performance

or functional

mobility.

In

conjunction

with

the

standard

series

of

questionnaires utilized in clinical studies, functional mobility, balance, and cardiorespiratory
function were assessed with objective laboratory tests.

Initially, a proposed objective was to investigate two groups of persons with T2D;
those with peripheral neuropathy and those without neuropathy. This would have enabled
the independent effect of neuropathy to be assessed with respect to neuromuscular
properties and functional mobility in persons with T 2 D .

neuropathy volunteered for this study.
volunteers

H ow ever,

no persons with

It was extremely challenging to recruit T2D

to participate in this study; highlighting the importance of hospital and clinic

investigators in becoming involved with university research, and indicating poor community
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relationship and interest with research in this particular region. Interestingly, all of the
persons who volunteered to participate in this project were “healthy” diabetics with extreme
interest in understanding their condition and prolonging function. Despite numerous and
various tactics to “excite” potential volunteers, or evoke interest in the community, a number
of attempts to recruit volunteers (Table 1) failed to attract more than twenty persons with
T2D over a one year period in the Windsor-Essex region. This may be related to the lack of
direct university interaction with a clinical hospital or endocrinology specialists.

Most

studies on contractile and neural function in persons with T2D have been conducted in
clinical research hospitals (e.g. Andersen e t al., 1997, 1998, 2004a, 2004b; Corriveau et al.,

2000 ).

All volunteers of the T2D population studied were free from neuropathy (Table 4) as
determined by self-report based upon physician consultation as well as standardized
questionnaires and physical screening (Feldman et al., 1994; Valk, De Sonnaville, Van
Houtum, Heine, Van Eijk, Bouter et al., 1997). Determination of health history, daily and
physical activity,

resting

heart rate and predicted submaximal V 0 2 (Table 3) also

established that the T2D and control groups did not differ and because the controls were
representative of others in their general age category in terms of mobility speed (Podsiadlo
& Richardson, 1991), physical activity scores, resting heart rate (King, Everett, Mainous, &
Liska, 2006), and predicted submaximal V 02 (Petrella, Koval, Cunningham, & Paterson,
2003) w e can infer that the T2D w ere also ‘healthy’ outside the diabetic state.

M oreover,

the significant difference in HbA1c and glucose between groups and the mean (8.4 ± 1.3 %;
8.33 ± 2.21 mmol/L, T2D and 6.1 ± 0.4 %; 5.50 ± 0.95 mmol/L, controls) data are similar to

49

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

standardized values for T2D diagnosis (CDA, 2007) substantiates that one group was
healthy T2D and the other healthy age, gender and activity matched controls.

Strength and Physical Function

Although the persons with T2D had higher baseline blood glucose levels and HbA1c
levels (Table 6), they performed similarly in tests of isometric strength and retain the ability
to maximally activate the TA when sufficient practice is given (Jakobi et al., 2001).
Irrespective of the condition of diabetes, the muscle strength data in this study was similar
to prior reports in the dorsiflexors (Vandervoort & McComas, 1986).

As well, twitch

contractile properties, peroneal nerve conduction velocity, and m-wave profiles were similar
between groups and comparable to the literature. Because electrically induced contractile
properties provide a strong indication of fibre type (Gorelick & Brown, 2007) and an indirect
assessment of Ca2+ dynamics during the cross bridge cycle (McComas, 1996) it is highly
unlikely that hyperglycaemia has induced fibre type or contractile function adaptations in
this healthy group of T2D subjects. Neuromuscular junction activity also seems to be
unaltered at this stage of diabetes, as evidenced by similar m-wave peak to peak
amplitude. Since human studies on contractile function are sparse, a continuum of change
due to disease progression is not possible. The data describing personal attributes of this
particular group of individuals suggests that they collectively represent “active” and
“health y” people (T a b le 3, 4 & 5) at the beginning of the dis ea s e continuum considering the

age of diagnosis, HbA1c and glucose levels (Table 2).

Thus, this study is the first to

quantify contractile measures in the early state of T2D.

In order to clearly establish the

progressive, but deleterious effect of hyperglycaemia, it is necessary to conduct a long-term
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study where contractile properties are monitored from diagnosis through loss of functional
independence.

Strength data from this study might differ from prior studies due to the stage of
disease progression at the time of study, as strength studies have investigated individuals
that are neuropathic and/or older adults. Van Schie, Vermigli, Carrington, & Boulton, (2004)
observed a decrease in strength in neuropathic individuals, compared to controls and
others have reported differences between neuropathic and non-neuropathic individuals
(Andersen e t al., 1997; Andreassen, Jakobsen, & Andersen, 2006).

It also seems that

many studies have included groups of older neuropathic individuals; this leads to the
question of whether the natural physiological process of aging exacerbates the deleterious
effect of hyperglycaemia reported in the animal literature (Cameron e t al., 1992; Fahim et
al., 1998; McGuire e t al., 2001) and in extreme states where glucose is ill-controlled
(Resnick et al., 2002). Had healthy older adults (less than 75 years) with T2D been
assessed the possible interrelationship between the diabetic condition and natural aging
might have been possible to clarify. Moreover, differences between this study and others
might have occurred due to the isometric measures of strength. Most studies utilize manual
muscle testing (Van Schie e t al., 2004), grip tests (Sayer et al., 2005) or isokinetic
dynamometry (Andersen et al., 1997, 1998; Andreassen e t al., 2006; Park, Goodpaster,
Strotmeyer, De Rekeneire, Harris, Schwartz e t al., 2006) to assess muscle strength.
Isom etric force m easures and utilization of the twitch interpolation technique facilitates the

study of an isolated muscle where minimal equipment is required and the movements are
readily learned and executed

(Jakobi et al., 2001).

Manual muscle testing,

hand

dynamometry and isokinetic measures of strength are subjective measures that are
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dependent upon whole body extrapolation. Furthermore, it is difficult to establish when
maximal performance has been learned and attained.

Physical activity was carefully monitored and matched between T2D and controls.
Although a few studies have matched for age and gender (Corriveau e t al., 2000; Meier et
al., 2001), no study to date has matched for physical activity. This is an important task as
strength and mobility are related to physical activity, and a major determinant of functional
mobility differences may be accounted for by participation in daily activity or exercise
(DiPietro e t al., 1993). When daily physical activity is matched, muscle strength was not
different between persons with T2D and non-diabetic controls, indicating that the diabetic
condition does not result in muscle weakness.

The human literature is unclear with respect to the relationship between conduction
velocity and hyperglycaemia.

0rskov, Worm, Schmitz, Mengel, & Sidenius (1994)

observed conduction velocity slowing, whereas Cappellari, Airaghi, Capra, Ciammola,
Branchi, Levi-Minzi e t al. (2005) observed no remarkable changes in conduction velocity.
In this study, neither blood glucose (Figure 7), nor HbA1c (Figure 8) were found to be well
correlated with peroneal nerve conduction velocity. The relationship may have escaped
detection in this study because the magnitude of change in peroneal nerve conduction
velocity is significantly greater in individuals with HbA1c greater than 8.5 % (Huang, Chen,
W en g , Lee, Tseng, & H uang, 2005).

T h e glucose and HbA1c levels in the T2D groups

were less in this study compared to others where relationships with conduction velocity
have been observed. It is likely that detectable differences in peroneal nerve function occur
in association with the onset of neuropathies due to chronic hyperglycaemia, because
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studies that include neuropathic individuals report difference in peroneal nerve function
(Resnick e t al., 2002). Thus, when glucose is carefully controlled peroneal nerve activity is
not altered due to hyperglycaemia; rather alterations in conduction velocity are associated
with development of neuropathies secondary to the diabetic condition.

These groups were well matched for all aspects of physical performance, daily
activity, and exercise participation, but functional balance was lower in T2D (53.1 ± 1.8)
compared with the controls (54.6 ± 1.1). Albeit a significant difference exists between the
groups, both scores are high (scored out of 56) suggesting no balance deficits (Powell &
Myers, 1995). Although balance was still good, the difference noted in the diabetic group
could be indicative of an early decline in neural function or blood flow prior to the outward
presence of foot ulcerations or loss of sensation because perception of balance confidence
did not differ between groups (Table 4).

It has been found that posture, gait and balance

change in both T2D and T1D (free from neuropathy) (Nicholson, King, Smith, & Darlington,
2002) possibly due to changes in the vestibulo-ocular and opto-kinetic reflex (Petrofsky et
al., 2004; Petrofsky, Lee, Macnider, & Navarro, 2005a; Petrofsky, Lee, & Cuneo, 2005b). It
is known that balance is modulated by musculoskeletal, visual and vestibular networks and
because strength and contractile properties were similar between groups it is highly unlikely
that the loss of balance in these persons with T2D was due to musculoskeletal adaptations.
No finite tests were conducted on the vestibular and visual system but, a few volunteers (4
with T2D) used corrective lenses, however, it is unknown when use of corrective lenses
began. It is unknown, and difficult to elucidate in most instances whether the reason for
wearing corrective lenses was related to T2D, but it is known that T2D may be manifested
in secondary disease of the ocular system.
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Regression analysis revealed a relationship between PT and TUG walking speed for
controls (R2=0.6964), yet in the T2D group there was virtually no association (R2=0.011).
Similarly, a relationship between predicted V 0 2 max from fast paced stepping was related
to MVC in controls (R2=0.6745), but was unrelated in the T2D group (R2=0.0081). It is
possible that knowledge of having a disease translates to performance that is impacted by
self-perception or confidence (Stewart, Turner, Bacher, DeRegis, Sung, Tayback et al.,
2003).

The individuals with T2D reported poorer perceptions of their health compared to

controls (Table 4). Because V 0 2 max and walking speed on the TUG are subjective to each
individuals effort it is possible that the T2D group did not reach peak values because of a
conviction that their physical/emotional health limited performance, whereas the attainment
of maximal on the subjective measure of performance resulted in a strong relationship with
objective measures of contractile function (PT, isometric strength) in the non-diabetic group.

Muscle Fatigue

Clinical reports from patients not only suggest muscle weakness but also fatigue
(Adriaanse, Dekker, Spijkerman, Twisk, Nijpels, Van der Ploeg, et al., 2005). To-date no
study has assessed muscle fatigue and recovery in T2D. In this study T2D and control
subjects underwent a modified isometric submaximal fatiguing exercise.

This fatigue

protocol which utilizes a 6:4 work to rest ratio has been employed for the study of muscle
en d u ran ce in disease e ls e w h e re (Jakobi e t al., 2001). H ow ever, for this study the work level

was increased to 75 %, rather than utilizing the traditional 50 % (Bigland-Ritchie, Furbush,
& Woods, 1986). A higher intensity was chosen because the phosphagen and anaerobic
energy systems

are

primarily utilized for short duration

intense activity, thus the
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contributions from aerobic metabolism; albeit active, were less in a 75 % work intensity
protocol compared with the traditional 50 % protocol. It was necessary to minimize aerobic
production of ATP because glucose levels are substantially higher in T2D compared with
controls, thus the effect of the aerobic system whereby carbohydrates are the primary
source of energy would have created an artificial ‘carbohydrate loaded’ condition. Pilot
studies indicated time to fatigue for the 50 % work intensity was 20-30 minutes, whereas for
the 75 % condition pilot data suggested time to fatigue would be 50 % less (8-12 minutes),
and the intensity was of sub-maximal level that would be tolerated by volunteers. The
neuromuscular components assessed during the fatigue protocol were voluntary force,
twitch interpolation, twitch contractile properties and muscle activity through surface iEMG.
Recovery was also studied through the utilization of identical measures to the fatigue task
in order to understand the re-establishment of homeostatic set-points in the diseased
versus the control group.

When exposed to an acute bout of a fatiguing exercise, the groups performed
similarly with respect to time to fatigue (4.9 ± 2.5 min T2D; 7.9 ± 5 . 1 control) at the same
relative work intensity. Maximal activation was assessed for the entire duration of the
fatiguing exercise with the twitch interpolation technique and central drive was maintained
in both groups. As suggested by these data, the decline in force was not due to an inability
to perform an MVC in either group. Collectively, the data from this study does not support
clinical reports of fatigue in persons with T 2 D .

It is possible that due to the anaerobic

nature of the fatigue protocol, the mechanism whereby fatigue occurs earlier in the diabetic
group was circumvented.

Furthermore, fatigue might be due to alterations in aerobic

metabolism. The T2D group had higher pre- and post-exercise glucose levels compared to
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controls, but the magnitude of change from pre to post fatigue was similar between groups.
This suggests that the ‘carbohydrate’ contribution to aerobic metabolism was similar
between groups. Because differences occur in specific enzymatic function at various steps
in biochemical pathways which are influenced by glucose concentrations it is plausible that
aerobic function may change in T2D (Bouche, Serdy, Kahn, & Goldfine, 2004). The
magnitude of change for pre and post-exercise blood lactate did not differ between groups
(P=0.72), but it seems that the change was ‘observably’ greater in T2D, possibly indicating
a greater emphasis on anaerobic metabolism. Since the limiting factor in aerobic
metabolism is oxygen availability, the trend to greater lactate production could be indicative
of limited oxygen perfusion in muscle, while this limitation may be consequent to early
systemic microvascular changes (Rask-Madsen & King, 2007). Overall, these ‘gross’
metabolic measures suggest that future studies should assess muscle fatigue in persons
with T2D and compare between aerobic and anaerobic exercises. These comparisons
might elucidate the mechanism to support the clinical reports of fatigue in persons with
T2D.

Twitch tension decreased to - 5 0 % in both groups, and this rate of decline was
similar between groups, and to studies of women with Addison’s Disease or older adults
(Jakobi e t al., 2000; 2001). Changes in contractile timing were similar between groups, but
slowing did not occur during the fatigue protocol. It is likely that slowing was not present in
this study because the duration of the fatigue protocol w as too short to induce contractile

slowing of the twitch; however, had tetanic force been studied contractile slowing might
have been evident. Twitches are less reliable (ICC 0.83) and much more affected by fatigue
than higher frequency responses (ICC 0.95) and thus 50 Hz contraction times are often
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utilized to assess rates of whole muscle activity (Edwards, Hill, Jones, & Merton, 1977;
Wiles, Young, Jones, & Edwards, 1979). An attempt to measure 50 Hz tetanic contractions
was made;

however due to technical difficulty in maintaining consistent electrode

placement, the contractile

responses were

unpredictable. This was determined

monitoring of stimulus artefact and electrical EMG

responses.

by

Overall, stimulated

contractile measures indicate that Ca2+ kinetics through the cross-bridge cycle and fibre
composition are unaltered in humans, as a consequence of hyperglycaemia. The animal
literature is equivocal with respect to fibre type changes (Fahim e t al., 1998; McGuire e t al.,
2001) but it seems that the more heterogeneous a muscle the less apt it is to change
proportion as a result of induced diabetes (Cameron et al., 1992).

Muscle activity was characterized by surface iEMG, and did not differ between
groups over the duration of the fatigue protocol. Consistent with other intermittent isometric
fatigue studies (Bigland-Ritchie et al., 1986; Jakobi e t al., 2000; 2001) submaximal iEMG
increased and maximal iEMG remained relatively constant during the fatiguing exercise.
This rise in submaximal iEMG is the result of motor unit recruitment and increases in
discharge rate (Conwit e t al., 2000). Although both groups of subjects demonstrated this
increase in submaximal iEMG it is known that at some point during a fatigue continuum
submaximal iEMG will meet maximal iEMG (Bigland-Ritchie e t al., 1986; Jakobi e t al., 2000;
2001) and this is the point of physiological muscle ‘exhaustion’. The T2D group and control
group did not reach this point; how ever, the increase in the submaximal iEMG corresponds

to the end-point of force loss (~80 %).
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There are no reports in the literature with respect to recovery subsequent to a
fatiguing exercise in persons with T2D. These data suggest that when force decline is
similar there is no difference in rate of recovery between persons with T2D and age, gender
and activity matched controls.

However, in this middle-aged group of men and women

voluntary force production remained significantly depressed at 10 minutes post-fatigue. It is
likely that lack of recovery may be partially attributed to muscle drive.

Although, central

drive as assessed with the twitch interpolation technique indicated that the muscle was fully
active, the maximal iEMG suggested that neural activity was slightly depressed during
recovery.

Overall, the diminutive disparity between the central activation data and the

iEMG data can be accounted for by the twitch interpolation data reflecting a very brief
moment (~0.5 s) of the MVC, whereas the EMG measures were averaged over the duration
of the 6 s contraction.

Together, these results indicate that when persons with T2D are age, gender and
physical activity matched to control subjects muscle strength, contractile function and
fatigue is unaltered. On the other hand, these persons experience psychosocial or
emotional consequences of being “diseased” as evidenced through self-report. Evidence
from this study serves to highlight the importance of preventing secondary disease
progression associated with chronically high levels of blood glucose.

Functional deficits

that have been reported previously in the literature (Dolan, Liu, Criqui, Greenland, Guralnik,
C han et al., 2002; G regg , M angione, C auley, Thom pson, S chw artz, Ensrud et al., 2002;

Volpato, Blaum, Resnick, Ferrucci, Fried, & Guralnik, 2002) may be linked to poor
glycaemic control that results in secondary diseases (i.e. neuropathies) over time, or
functional decline may be exaggerated by the complex interplay of the physiological
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process of aging.

This study clearly measured strength and function in non-neuropathic

adults prior to an age where physiological changes of aging would be of primary concern
(McNeil et al., 2005). This study purports that clinical self-reports of muscle weakness,
fatigue and functional decline are likely related to the psychological impact of diagnosis of a
‘disease’. In such cases, it is critical that these people receive accurate feedback on their
disease from practitioners in addition to appropriate social support. The issue is not denying
the condition exists, but focusing and conveying that impaired glucose control in itself does
not indicate immediate functional change and that persons with T2D are as ‘able’ as non
diabetic age, gender and activity matched controls. These results are good news for those
individuals who are challenged with glucose management.

Conclusions

This study represents the first attempt to incorporate measurements of
isometric contractile properties, strength, functional mobility and fatigue in persons with
T2D, who are age, gender and activity matched to controls. To-date there has been no
attempt to utilize physical activity as a component of subject matching. Because, exercise
and physical activity are an integral component of muscle strength (Dreyer, Schroeder,
Hawkins, Marcell, Tarpenning, Vallejo et al., 2006) and functional mobility (Scott, Votora,
Scanlan, & Close, 2007) extreme care was taken with subject matching. Unlike many other
studies conducted on persons with T 2 D , results from this e xp e rim en t indicate that w hen

activity is accounted for muscle strength and fatigue are not reduced as a consequence of
hyperglycaemia. This study provides a key example of the need to assess physical activity
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when alterations in strength and physical function are being evaluated with respect to a
pathological condition.

The unique aspect of this study were the combined utilization of objective physical
performance and muscle function tests with subjective measures of functional mobility,
performance and health perception, in a group of relatively healthy, well-controlled persons
with T2D.

The

combination

of assessment of health

perception with

quantitative

performance tests enabled elucidation of information with respect to how individuals who
perceive their health negatively, have lower scores on subjective performance tests but do
not differ from age, gender and activity matched controls on objective physical function
tests that control for motivation and effort (twitch interpolation, twitch contractile properties).
This work serves to highlight the importance of how disease perception can negatively
impact physiological function. Moreover, these data elucidate the necessity and importance
of early detection, glucose regulation and exercise adherence.

When these are occur

persons with T2D do not differ from age, gender and activity matched non-diabetic persons.
This work underlines the need for clinicians to convey to persons with T2D, that this is not a
debilitating disease, as long as glucose is controlled through physical activity in conjunction
with standard pharmacological and diet manipulation techniques. The impact of healthperception and emotion on subjective physical function should not be underestimated, and
thus reports of fatigue and weakness should be considered in conjunction with self
perception of health.

Although there were no significant differences between T2D and controls, the overall
message of these results is not only very important for clinicians but persons who live with
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T2D. Both populations should not underestimate how perceptions of health and exercise,
influence physiological function. While the trend of most disease related studies is to focus
on the critically affected to reveal significant changes from the healthy condition, and oft
times the outcome message is negative, yet the impact of this study from well-managed
individuals is inverse, and should not be underestimated.

Hence, this study enables

persons with T2D with a positive message of the benefit of exercise and glucose control.

Considerations for Future Research

1.

Future studies should consider evaluating physical function and strength in
conjunction with perceptions of health in persons with T2D who are neuropathic
and in a group who undertake regular exercise at moderate to intense levels to
understand the extent that neuropathy effects strength and function before the
onset of age-related changes, and whether individuals who exercise are much
different from individuals who perform moderate to little exercise (exemplified in
this study).

2.

A questionnaire with respect to self-perception of muscle fatigue and weakness
needs to be developed and evaluated in conjunction with any future tests of
muscle function or strength so that a direct link between self-perceived ability and
objective m e as u re s of function can be m ade.
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3.

A study to assess physical function, strength and nerve function in healthy
persons without T2D who are subjected to glucose infusion to observe the acute
effects of hyperglycaemia.

4.

Since motor unit function is critical to force modulation,

a study evaluating

discharge rates and recruitment during isometric force production in middle-aged
neuropathic individuals with T2D might reveal whether losses in strength reported
elsewhere are due to inherent changes to the motor unit when age is not a factor.

5.

The results of this study suggest that individuals who have T2D do not fatigue
differently when exposed to an anaerobic fatigue task, yet a common report in
T2D along with weakness is fatigue. An aerobic 50% submaximal intermittent
fatigue protocol would be useful for comparison with this study and enable
determination of muscle fatigue due to metabolic alterations that are inherent to
T2D (i.e. glucose which is the primary substrate for aerobic metabolism).
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APPENDICES
Appendix A. Research Ethics Approval, Consent and Information Forms

f t

O N I V £ ft S I T Y

OF

WINDSOR
O FFIC E OP RESEARCH SERVICES
RESEARCH

E T H IC S

BOARD

Today’s Date:
Principal Investigator:
Department/School:
REB Number:
Research Project Title:

October 12, 2005
Ms. Lynette Singh
Kinesiology
05-146
Characterization of neuromuscular properties: functional mobility and
fatigue in persons with Type 2 Diabetes mellitus
Clearance Date: October 12, 2005
Project End Date: July 31,2006

Progress Report Due:
Final Report Due: July 31, 2006

This is to inform you that the University of Windsor Research Ethics Board (REB), which is organized and
operated according to the Tri-Council Policy Statement and the University of Windsor Guidelines fo r Research
Involving Human Subjects, has granted approval to your research project on the date noted above. This approval
is valid only until the Project End Date.
A Progress Report or Final Report is due by the date noted above. The REB may ask for monitoring information
at some time during the project’s approval period.
During the course of the research, no deviations from, or changes to, the protocol or consent form may be
initiated without prior written approval from the REB. Minor change(s) in ongoing studies will be considered
when submitted on the Request to Revise form.
Investigators must also report promptly to the REB:
a) changes increasing the risk to the participant(s) and/or affecting significantly the conduct of the study;
b) all adverse and unexpected experiences or events that are both serious and unexpected;
c) new information that may adversely affect the safety of the subjects or the conduct of the study.
Forms for submissions, notifications, or changes are available on the REB website: www.uwindsor.ca/reb.
We wish you every success in your research.

Dr. Maureen Muldoon
Chair, Research Ethics Board
cc:

Dr. Jennifer Jakobi, Kinesiology
I Linda Bunn, Research Ethics Coordinator

This is an official document. Please retain the original in your files.
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t t
UNI VERSI TY

OF

WINDSOR
CONSENT TO PARTICIPATE IN RESEARCH
Title of study: Characterization of Neuromuscular Properties, Functional Mobility and
Fatigue in Persons with Type 2 Diabetes mellitus
You are asked to participate In a research study conducted by Lynette Singh, Dr. Jennifer Jakobi and Dr. Kenji Kenno, from
the Department of Kinesiology, Faculty of Human Kinetics at the University of Windsor. The results of this study will
contribute to Lynette Singh’s thesis project to complete the candidacy for Masters of Human Kinetics (MHK) degree.
If you have any questions or concerns about the research, please feel to contact:
Lynette Singh, BScH
Department of Kinesiology
Faculty of Human Kinetics
Neuromuscular Laboratory, rm 231
University of Windsor
Windsor, Ontario N9B 3P4
Tel.
(519) 253-3000 ext. 4049
E-mail: singh3d@uwindsor.ca

PURPOSE OF THE STUDY
Skeletal and neural tissues are central to our ability to generate force for ail movement. In persons living with diabetes, the
neural and muscular systems may be affected by high blood glucose. This seems to create problems with performance of
daily tasks, affecting personal autonomy and overall quality of life. Currently, much of the information that is known about
the neuromuscular system in diabetes comes from animal models, while information gathered from human studies is sparse.
The goal of this study is to quantify and compare muscle properties from the tibialis anterior of healthy middle-aged adults to
persons with Type 2 diabetes. Electrophysiological data will be compared to the results of functional mobility performance
indicators and questionnaires to see if any relation exists between physical performance and any changes in neuromuscular
function. This information will show how persons with Type 2 diabetes differ from healthy individuals and ultimately aid in
understanding mechanisms of the decline in physical function. In addition, possible neuromuscular differences found during
a fatigue protocol will be utilized to highlight changes in muscle function that may result, and could offer plausible insight to
the muscle weakness that is experienced by some people living with Type 2 diabetes.

PROCEDURES
Day 1 - Part A: Questionnaires and Familiarization Session
After arriving at the Neuromuscular laboratory, you will be asked to complete the Letter of Consent and receive the Letter of
Information. Ail information gathered will be coded to ensure anonymity and will be kept confidential in a locked cabinet. You
will be asked to complete a Background Questionnaire, the Yale Physical Activity Survey for Older Adults, the Waterloo
Footedness Questionnaire (WFQ) and The Medical Outcomes Study (MOS) Questionnaire, the Diabetes Self-Efficacy Scale
(OSES) and the Activities-specific Balance Confidence scale (ABC scale).
In the Multi-purpose room in the St. Denis Centre, you Will be asked to participate in a Timed-up and go (TUG), step test
(STEP), self-paced walk (SPW), Berg Balance Scale (BBS), and the 4m timed walk test with rest periods in between.

Day 1 - Part B: Sensory Tests
To distinguish neuropathic and non-neuropathic persons, initial screening will be conducted by sensory testing using a 10-g
Semmes-Weinstein monofilment (nylon brush) that will be applied lightly to the back of each great toe below the cuticle on
the skin 10 times In different places. You will be asked to complete the Michigan Neuropathy Screening Instrument (MNSI) In
addition to the initial sensory testing.
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Day 1 - Part C: Glycosylated Hemoglobin Test
All persons will receive a glycosylated hemoglobin test from a single drop of blood obtained using standard sampling
techniques that are the same as finger prick testing used for blood glucose measurements.

Day 2: Electrophysiological Testing
Before the neuromuscular study, you will be asked to refrain from consuming caffeine for at least 2 hours prior. Blood
glucose will be measured using a standard glucose meter. Blood lactate will be measured at the same time, using a standard
lactate sampling technique.
You will be seated with your non-dominant leg in a device to measure force Your non-dominant leg will be secured using a
series of straps at the foot, and padded leg clamps to keep your leg in position. At rest, a non-adhesive electrode will be
connected to a stimulator and will be placed on the surface of the skin over your shin and utilized to assess twitch contractile
properties. Electrical activity will be recorded by attaching self-adhering button electrodes to the skin over your shin region. In
the first part, with the muscle at rest, your lower leg muscle over the front of your lower leg (tibialis anterior) will be maximally
stimulated. This stimulation begins at low and progressively increases until the muscle responds without the interference of
the calf muscles. In the second part of the neuromuscular investigation, you will be asked (in same seated position) to force
your toes upwards as hard and as fast as possible and hold the position for 3 seconds (maximum voluntary contraction,
MVC) and will be allowed to monitor your progress.The interpolated twitch technique involves application of a maximal
electrical stimulus to the nerve in your leg prior to, during and after a maximum voluntary contraction (MVC). You will be
asked to perform three MVCs separated by 5 minutes of rest. One to two MVCs will be performed before testing to
familiarize you with the technique. In a fatigue test, you will be asked to exert muscle force in your leg until your muscle
fatigues. At the end of this test, your blood glucose and blood lactate levels will be measured again. Day 2 will take
approximately 1 hour to complete.

POTENTIAL RISKS AND DISCOMFORTS
There is always a risk when performing any physical activity, but the risk associated with these tests do not exceed the risk
of performing activities of daily living. With the use of surface EMG electrodes a minimal risk of minor skin irritation exists, but
is similar to that of wearing a bandage. A standard minimal risk (similar to "at home tests’) may be associated with blood
work in the neuromuscular laboratory, but sterile precautions for use and disposal of lancets will be taken.

POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
There is evidence to suspect that people with Type 2 diabetes are different from healthy individuals. At present, however,
there is very little information available regarding electrophysiological characteristics of muscle in Type 2 diabetes. To date,
no study has combined electrophysiological tests, nor assessed fatigue in conjunction with such a variety of physical
performance tests and questionnaires to gather a gradation of information concerning how the body adapts physiologically to
this disease.
This study provides volunteers an opportunity to participate in research that could provide information to advance current
knowledge about diabetes, information that may help in the advancement of more suitable exercise prescriptions and
treatment for Type 2 diabetes. Volunteers will gain a greater self-awareness from completion of questionnaires and mobility
tests and will have an opportunity to see their glycosylated haemoglobin levels.

PAYMENT FOR PARTICIPATION
All subjects will receive a gift package containing information about general health and diabetes, sample products and a
cookbook (total value approximately $30.00).

CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be identified with you will remain confidential and
will be disclosed only with your permission. All data from subjects will be collected and coded for anonymity at the beginning
of the study session.
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PARTICIPATION AND WITHDRAWAL
YOU can choose whether to be in this study or not. If you volunteer to be In this study, you may withdraw at any time without
consequences of any kind. You may also refuse to answer any questions you do not want to answer and still remain in the
study. The investigator may withdraw you from this research if circumstances arise which warrant doing so. Any persons
with musculoskeletal disorders, injury, other neurological disorders or painful neuropathy, myopathy, severe cardiovascular
disease, have a pacemaker, recovering from surgery, alcoholism, pregnancy, or extreme physical activity patterns are
unsuitable candidates for this study and will be excluded.

FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
You will receive information about your glycosylated haemoglobin levels. Because this experiment Involves the use of non
diagnostic tests, the results of each test will not be available until cumulative group averages are found. Study results will be
published on the University of Windsor ethics website at www.uwindsor.ca/reb for you to look through at the final completion
of the investigation.

SUBSEQUENT USE OF DATA
This data will be used in subsequent studies.
Do you give consent for the subsequent use of the data from this study?

□

Yes

□

No

RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without penalty. This study has been reviewed and
received ethics clearance through the University of Windsor Research Ethics Board. If you have questions regarding your
rights as a research subject, contact:
Research Ethics Coordinator
University of Windsor
Windsor, Ontario N9B 3P4
Tel. (519)253-3000 ext. 3916
E-mail: lbunn@uwindsor.ca

SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE
I understand the information provided for the study Characterization of Neuromuscular Properties, Functional Mobility
and Fatigue in Persons with Type 2 Diabetes mellltus as described herein. My questions have been answered to my
satisfaction, and I agree to participate in this study. I have been given a copy of this form.

Name of Subject

Signature of Subject

Date

SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.

Signature of Investigator

Date
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Appendix B. Recruitment Advertisements

Researchers at the University of Windsor are looking for
individuals WITH and WITHOUT Type 2 Diabetes to
participate in a study to look at mobility and strength.
Volunteers between the ages of 40-65 can have a free
glycoiated haemoglobin test.
If you are male or female between the ages of 40-65
and would like more information

PLEASE CONTACT
Lynette Singh or Jennifer Jakobi, PhD
(519)253-3000 extension 4049
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NEEDED
Individuals between 40-65 years
of age with and without Type 2
Diabetes
Researchers at the University of Windsor are conducting
a study to examine mobility and muscle characteristics in
persons with Type 2 Diabetes
Volunteers between the ages of 40-65 can have a free
glycolated hemoglobin test.

For further Information, PLEASE CONTACT:
Lynette Singh or Jennifer Jakobi, PhD
(519)253-3000 extension 4049
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Researchers at the University of W indsor are
looking for individuals to participate in a study to
look at mobility and strength.

If you are male or female between the ages of 40-65
and would like more information

PLEASE CONTACT
Lynette Singh or Jennifer Jakobi, PhD
(519)253-3000 extension 4049
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Campus-wide Email
Volunteering Opportunity at the University of Windsor
I am a Master of Human Kinetics student who is currently working on my
research project which focuses on understanding the relationship between
strength and mobility. W e are inviting you to participate in this project. Currently,
I require participants who have been diagnosed with Type 2 diabetes as well as
individuals who do not have diabetes that are between 40 to 65 years of age.
This project involves general health questionnaires, mobility/walking tests and
strength assessment. This study has received approval from the University of
Windsor Research Ethics Board. If you would like more information I (or my
supervisor) would be happy to chat with you about the specifics of my Master’s
project.
Thanks for your consideration,
Lynette A. Singh, BScH
Master’s Candidate
University of Windsor
Faculty of Human Kinetics
Department of Kinesiology
Human Kinetics Bldg., Rm. 231
Telephone: 519-253-3000 ext. 4049
Email: singh3d@uwindsor.ca
Jennifer M. Jakobi, PhD
University of Windsor
Faculty of Human Kinetics
Department of Kinesiology
Human Kinetics Bldg., Rm. 120
Telephone:519-253-3000 ext.2473
Email: jjakobi@uwindsor.ca
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Appendix C. Questionnaires, Blood and Neuropathy Screening
Session One. Familiarization Session Checklist
Subject Code
Date

I |Consent Form (in file)
I ILetter of Information (to subject)
Q Subject Contact Information (in confidential file)

I]
I]
I]
0
0
3]

I
I
0
1
I

Background Questionnaire (subject file)
Waterloo Footedness Questionnaire (subject file)
The Yale Physical Activity Survey for Adults (subject file)
SF-36 (subject file)
The Diabetes Self-Efficacy Scale (subject file)
The Activities-specific Balance and Confidence Scale (subject file)

1The Berg Balance Scale (subject file)
IThe Timed “U p and G O ” test (subject file)
The 4-metre timed walk (subject file)
IStep Test Exercise Prediction of V O 2 m a x (subject file)
|The Michigan Neuropathy Screening Instrument Questionnaire (subject file)

I |Neuropen Sensory Testing (subject file)
Test (subject file)

l~1 H b A l c

I |Schedule second session to the lab
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or

WINDSOR
Day Two: Your Next Visit to the Neuromuscular Laboratory

Thank you very much for participating in the first part of the study. In order for
us to complete this study, we ask that you come back to the laboratory for the
second part (*) (**).

Your next visit is scheduled on:

*Please refrain from consuming any caffeine for at least 2 hours prior to this
visit.
**Bring a pair of comfortable shorts and socks along with you.

Neuromuscular Laboratory
Room 231
Human Kinetics Building

Please contact us if you need to reschedule this visit.
Department of Kinesiology
University of Windsor
Windsor, Ontario N9B 3P4

Tel. 1(519) 253-3000 e x t 4049
E-mail: singh3d@uwindsor.ca
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Session Two. N eurom uscular A ssessm ent

Subject Code
Date
Non-Dominant Leg
Tested

SG Excitation

SG Sensitivity

taEMG Amplifier

taEMG Gain

High Pass

Low Pass

lgEMG Amplifier

lgEMG Gain

High Pass

Low Pass

A. Conduction Velocity and Supramaximal Twitch
Q 10 single twitches to analyze
M ax M -wave/Twitch

Pulse Duration

Distance (mm)

Stimulator electrode to Active sEhdG electrode:

Current

Voltage

File Name

B .M V C

□ 1-3 x Practice MVC
□ 3 x MVC to Analyze
File Name

C. F a tig u e
B lo o d A n a ly s is - P A R T O N E

Time

Hours since last consum ed food

Blood Lactate Before

Blood G lucose Before

Blood Lactate After

Blood G lucose A fter

Fused Tetanus

Pulse Duration

Current

Voltage

1
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Fatigue Exercise plus 1 m inute Recovery
File N a m e

F a tig u e R e c o v e ry a fte r 3 m in u te s R e c o v e r y

File Name

F a tig u e R e c o v e ry a fte r 5 m in u te s R e c o v e r y

File Name

F a tig u e R e c o v e ry a fte r JO m in u te s R e c o v e r y

File Name

2
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Session One, Subject Contact Information
Name
Street Address
City
Province
Postal Code
Email
Phone Number
Emergency Contact
Emergency Contact N umber
Subject Code

95

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Session One. Background Questionnaire
Subject Code

Section 1. Tell us about yourself.
Sex
Age
Date of Birth
Weight (kg)
Height (cm)
Girth Measurement (cm)
W:

Section 2. Tell us about your health
Are you a regular smoker?

No
Yes

D o you consider yourself...

At the Right Weight
Overweight
Underweight

Are you a frequent dieter?

No
Yes

Have you had surgery in the past year?

No
Yes
If so, type

Have you ever been diagnosed by a health
professional as having any of the following?
(Check all that apply, mak e specifications
where applicable)

Heart trouble
Arthritis
High Blood Pressure
High Cholesterol
Cardiac Pacemaker
Electronic Implant
Back problems
Foot Problems
Muscle Problems
Bone or Joint Disorder
Previous Injury
Alcoholism
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Allergies (including hay fever and sinus problems)

Difficulties hearing
Difficulties seeing
Other health problems

Family history of diabetes?

Diabetes
if YES, please complete
Section 3
No
Yes
If so, please provide details

Are you currently using any medications?

Section 3. Tell us about your diabetes
H o w many years has it been since you were first
diagnosed with Type 2 diabetes?
D o you receive regular medical care for your
diabetes? (such as visits to a family physician,
specialist etc.)
What level do you control your blood sugar?

What method(s) do you use to control Type 2
diabetes? (please check all that apply, provide
details ifapplicable)

Have you received educational counselling with
respect to controlling Type 2 diabetes?

Regular exercise
Weight loss
Special diet
Medications (please
possible)

state

which

type(s)

if

Other
Family physician
Diabetes educator
Endocrinologist
Dietician
Other

T h a n k you for completing this background questionnaire. The information provided will assist in
completion of this study. If you have found any of the sections unclear, please bring it to the
attention o f the experim enter.
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Session One.

Waterloo Footedness Questionnaire - Revised

Instructions: Answer each of the following questions as best you can. If you always use one foot to perform the described activity,
circle R i or La (for right always or left always). If you usually use one foot circle Ru or Lu, as appropriate. If you use both feel
equally often, circle Eq.
Please do not simply circle one answer for all questions, but imagine yourself performing each activity in turn, and then mark the
appropriate answer. If necessary, stop and pantomime the activity.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.

Which foot would you use to kick a stationary ball at a target straight in front of you?
If you had to stand on one foot, which foot would it be?
Which fool would you use to smooth sand at the beach?
If you had to step up onto a chair, which fool would you place on the chair first?
Which foot would you use to stomp on a fast-moving bug?
If you were lo balance on one foot on a railway track, which foot would you use?
If you wanted to pick up a marble with your toes, which foot would you use?
If you had to hop on one foot, which foot would you use?
Which foot would you use to help push a shovel into the ground?
During relaxed standing, people initially put most of their weight on one fool, leaving the
other leg slightly bent. Which foot do you put most of your weight on first?
Is there any reason (i.e. injury) why you have changed your foot preference for any o f the
above activities?
Have you ever been given special training or encouragement to use a particular foot for
certain activities?
If you have answered YES for either question 11 or 12, please explain:

La
La
La
La
La
La
La
La
La
La

Lu
Lu
Lu
Lu
Lu
Lu
Lu
Lu
Lu
Lu

Eq
Eq
Eq
Eq
Eq
Eq
Eq
Eq
Eq
Eq

Ru
Ru
Ru
Ru
Ru
Ru
Ru
Ru
Ru
Ru

Ra
Ra
Ra
Ra
Ra
Ra
Ra
Ra
Ra
Ra

YES NO

(circle one)

YES NO

(circle one)
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Session One. The Y ale Physical Activity Survey for Older Adults

INTERVIEWER: PLEASE MARK TIME: ____ :_____:_____
HR
MIN
SEC
INTERVIEWER: (Please hand the subject the list of activities while reading
this statement). Here is a list of common types of physical activities.
Please tell me which of them you did during a typical week in the last month.
Our interest is learning about the types of physical activities that are a
part of your regular work and leisure routines.
For each activity you do, please tell me how much time (hours) you spent
doing this activity during a typical week. (Hand subject card HI.)
Intensity
Work

Ti m e

Code*

(Hrs/Wk) (kcal/min)
3.5

shopping (e.g., grocery, clothes)
Stair climbing while carrying a load
Laundry (time loading, unloading, hanging, folding only)

8.5
____

3 -°

Light housework: tidying, dusting, sweeping; collecting
trash in home; polishing; indoor gardening; ironing
___

3.0

Heavy housework: vacuuming, mopping; scrubbing floors
and walls; moving furniture, boxes, or garbage cans

4.5

____

Food preparation (10+ mins in duration): chopping
stirring; moving about to get food items, pans

2.5

Food service (10+ mins in duration): setting table;
carrying food; serving food

2.5

Dish washing (10+ mins in duration): clearing table;
washing/drying dishes, putting dishes away

2.5

Light home repair: small appliance repair;
light home maintenance/repair

3.0

Heavy home repair: painting, carpentry,
washing/polishing car

5.5

Other:

*
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Intensity
Time
code*
(Hrs/Wk) (keal/min)
Yardwork
____

4.5

Lawn mowing (walking only)______________________________ ____

4.5

Clearing walks/driveway: sweeping, shoveling, raking

5.0

Gardening: planting, weeding, digging, hoeing

Other:

____

__________________________________________

+

Caretakina
Older or disabled person (lifting, pushing wheelchair)

_______

childcare (lifting, carrying, pushing stroller)

5.5
4.0

Exercise
Brisk walking (10+ mins in duration)

6.0

Pool exercises, stretching, yoga

3.0

Vigorous calisthenics, aerobics

6.0

Cycling, exercycle

6.0

Swimming (laps only)

6.0

Other:_________________________________________________

+

Recreational activities
Leisurely walking (10+ mins in duration)

3,5

Needlework: knitting, sewing, needlepoint, etc.

1.5

Dancing (mod/fast): line, ballroom, tap, square, etc.

_______

5.5

Bowling, bocci

3.0

Golf (walking to each hole only)

5.0

Racquet sports: tennis, racquet ball

7.0

Billiards

2.5

Other: _______ ______

+
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INTERVIEWER: (please read to subject) . I would now like to ask you about
certain types of activities that you have done during the past month. I will
ask you about how much vigorous activity, leisurely walking, sitting,
standing, and some other things that you usually do.
1.

About how many times during the month did you participate in vigorous
activities that lasted at least 10minutes andcausedlarge increases
in
breathing, heart
rate, or leg fatique sccaused youtoperspire? (Hand
subject card /2.)
SCORE:

2.

0 = Not at all (go to Q3)
1 = 1-3 times per month
2 = 1-2 times per week
3 = 3 - 4 times per week
4 = 5 + times per week
7 = Refused
8 = Don't know
FREQUENCY SCORE

=

____________

About how long do you do this vigorous activity(ies) each time? (Hand
subject card #3.)
score:

o = Not applicable

1 = 10-30 minutes
2 = 31-60 minutes
3 = 60+ minutes

7 = Refused
8 = Don't know
DURATION SCORE

=__ _____________

WEIGHT =

5

VIG0R0U8 ACTIVITY INDEX SCORE:
FREQ SCORE ___
X DUR SCORE
x WEIGHT
(Responses of 7 or 8 are scored as missing.)
3.

= _____________

Think about the walks you have taken during the past month. About how
many times per month did you walk for at least 10 minutes or more
without stopping which was not strenuous enough to cause large increases
in breathing, heart rate, or leg fatigue or cause you to perspire? (Hand
subject card t2 .)
SCORE:

0 = Not at all (go to Q5)
1 = 1 - 3 times per month
2 = 1 - 2 times per week
3 - 3-4 times per week
4 = 5 + times per week
7 = Refused
8 = Don't know
FREQUENCY SCORE

=

____________
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4.

when you did this walking, for how many minutes did you do it? (Hand
subject card /3.)
SCORE;'

0 = Not applicable
1 = 10-30 minutes

2 = 31-60 minutes
3 = 60+ minutes
7 = Refused

8 = Don't know
DURATION SCORE

=

WEIGHT

=

FREQ SCORE
X DOR SCORE ___ p X WEIGHT __
(Responses of 7 or 8 are scored as missing.)

=

______________
4

LEISURELY WALKING INDEX 8CORE:

5.

______________

About how many hours a day do you spend moving around on your feet while
doing things? Please report only the time that you are actually moving.
(Hand subject card #4.)
SCORE:

0 = Not at all
l = less than 1 hr per day
2 = 1 to less than 3 hrs per day
3 = 3 to less than 5 hrs per day
4 = 5 to less than 7 hrs per day
5 = 7 + hrs per day
7 = Refused
8 = Don't know
MOVING SCORE

=

;________

WEIGHT =
MOVING INDEX SCORE:
MOVING SCORE ______ X WEIGHT
(Responses of 7 or 8 are scored as missing.)
6.

3

=__ ______________

Think about how much time you spend standing or moving around on your
feet on an average day during the past month. About how many hours per
day do you stand? (Hand subject card #4.)
SCORE:

0 » Not at all
1 = less than 1 hr per day
2 = 1to less than 3 hrs per day
3 = 3to
less than 5 hrs per day
4 = 5to less than 7 hrs per day
5 = 7 + hrs per day
7 = Refused
8 = DK
STANDING SCORE

=

______________

WEIGHT

=

2
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STANDING INDEX SCORE:
STANDING S CORE ______

X W E I G H T ___ =

(Responses of 7 or 8 are scored as missing.)
7.

About how many hours did you spend sitting on an average day during the
past month)(Hand subject card /5.)
score:

o ■* Not at all
1 = less than 3 hours
2 - 3 hours to less than 6 hours
3 = 6 hours to less than 8 hours
4 = 8 + hours
7 » Refused
8 = Don't know
SITTING SCORE
WEIGHT

=
=

_______________
1

SITTING INDEX.SCORE:
SITTING SCORE _____ X WEIGHT ___
(Responses of 7 or 8 are scored as missing.)
8.

=

_

About how many flights of stairs do you climb up each day? (let 10 steps
= 1 flight.)

Please compare the amount of physical activity that you do during other
seasons of the year with the amount of activity you just reported for a
typical week in the past month. For example, in the summer, do you do
more or less activity than what you reported doing in the past month?
(INTERVIEWER: PLEASE CIRCLE THE APPROPRIATE SCORE FOR EACH SEASON.)

Spring
Summer
Fall
Winter

Lot
Mere

Little
More

Same

Little
Less

Lot
Less

1.30
1.30
1.30
1.30

1.15
1.15
1.15
1.15

1.00
1.00
1.00
1.00

0.85
0.85
0.85
0.85

0.70
0.70
0.70
0.70

SEASONAL ADJUSTMENT SCORE = SUM OVER ALL SEASONS /

Don't know

4

INTt'KVJLEWEk P LEASE MA R K TIME:
HR

:______
SEC
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MIN

CARD #1

W E E K L Y PHYS I C A L ACTIVITIES

Work
Shopping (e.g., grocery, clothes)
stair climbing while carrying a load
Laundry
Light Housework:

tidying, dusting, sweeping,
collecting garbage in home,
polishing, indoor gardening,
ironing

Heavy Housework:

vacuuming, mopping, scrubbing
floors and walls, moving
furniture, moving boxes or
garbage cans

Food preparation (10+ min.):

chopping, stirring, moving
around to get food items, pots
or pans

Food service (10+ min.):

setting table, carrying food,
serving food

Dish washing (10+ min.):

clearing table, washing and
drying dishes, putting dishes
away

Light home repair:

small appliance repair, light
household maintenance and
repair tasks

Heavy home repair:

painting, washing and
polishing car, carpentry

Other:
Yardwork

Gardening:

pruning, planting, weeding,
hoeing, digging

Lawn mowing (walking only)
Clearing walks and driveway:

raking, shoveling, sweeping

Other:
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Caretaklncr

Older or disabled person:

lifting, pushing wheelchair

Childcare:

lifting, pushing stroller

Exercise
Brisk walking for exercise (10+ min.):

causes large increases in
heart rate, breathing or leg
fatigue

Stretching exercises, yoga, pool
exercise
Vigorous calisthenics, aerobics:

causes large increases in
heart rate, breathing or leg
fatigue

Cycling, exercycle
Lap swimming
other:
Recreational Activities
Leisurely walking (10+ min.)
Hiking
Needlework:

knitting, sewing, crocheting,
needlepoint

Dancing (mod/fast):

line dancing, ballroom,
square, tap, etc.

Bowling, boccie
Golf (walking to each hole only)
tennis, racquetball

Racquet sports:
Billiards
Other:

105

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CARD #2

Not at a ll
1-3 times per month
1-2 times per week
3-4 times per week
5 or more times per week
Don't know
CARD #3
10-30
31-60
60 or
Don't

minutes
minutes
more minutes
know

CARD #4
Not at a ll
less
than 1 hourper day
1 to
less than 3 hours per day
3 to
less than 5 hours per day
5 to
less than 7 hours per day
7 or more hours per day
Don't know
CARD /5
Not at a ll
less than 3 hours per day
3 hours to less than 6 hours per day
6 hours to less than 8 hours per day
8 or more hours per day
Don't know
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Session One. Medical Outcomes Study: 36-Item Short Form Survey Instrument
RAND 3 6 -Ite m Health Survey 1.0 Questionnaire Item s

;; 1. In general, would you say your health Is:
Excellent

1

Very good

2

; Good

3

Fair

4

Poor

5

: 2. Compared to one year ago, how would your rate your health in general now?

i

Much better now than one year ago

1

Somewhat better now than one year ago

2

About the same

3

Somewhat worse now than one year ago

4

Much worse now than one year ago

5.

The following items are about activities you m ight do during a typical day. Does your health now lim it you in these activities? If
so, how much?
(Circle One Number on Each Line)

Yes, Limited a
Lot

Yes, Limited a
Little

No, Not limited
at All

3. Vigorous activities, such as running, lifting heavy objects,
participating in strenuous sports

in

[2 ]

[3]

4. Moderate activities, such as moving a table, pushing a vacuum

in

[2 ]

[3]

5. Lifting or carrying groceries

[i]

[2]

[3]

6. Climbing several flights of stairs

Hi

[2]

[3]

I 1!

[2]

[3]

cleaner, bowling, or playing golf

7. Climbing one flight of stairs
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8, Bending, kneeling, or stooping

[1 ]

[2 ]

[3 ]

9. Walking m ore th an a m ile

[1 ]

[2 ]

[3 ]

10. Walking several blocks

[1 ]

[2 ]

[3 ]

11. Walking one block

[1 ]

[2 ]

[3]

12. Bathing or dressing yourself

[1 ]

[2 ]

[3]

During the past 4 w ee ks, have you had any o f the following problems w ith your w ork o r other regular daily activities as a result
of your physical health?
(Circle One N um ber on Each Line)

Yes

No

13. Cut down the am ount of tim e you spent on w ork or other activities

1

2

14. Accomplished less than you would like

1

2

15. Were limited In the kind of w ork or o ther activities

1

2

16. Had difficulty performing the work or other activities (fo r example, it took extra effort)

1

2

During the past 4 w eeks, have you had any of the following problems w ith your w ork or other regular daily activities as a result
o f any em otional problem s (such as feeling depressed or anxious)?
(C ircle One N um ber on Each Line)

Yes

No

17. Cut down the am ou nt of tim e you spent on work or other activities

1

2

18. Accomplished less than you would like

1

2

19. Didn't do work or other activities as carefully as usual

1

2
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20. During the past 4 w eeks, to w hat extent has your physical health or emotional problems interfered with your normal social
activities with family, friends, neighbors, or groups?
(Circle One N um ber)
Not at all 1
Slightly 2
Moderately 3
Quite a bit 4
Extremely 5
21. How much bodily pain have you had during the past 4 weeks?
(Circle One N um ber)
None 1
Very mild 2
Mild 3
Moderate 4
Severe 5
Very severe 6
22. During the past 4 w eeks, how much did pain interfere with your normal work (including both work outside the home and
housework)?
(Circle One Num ber)
Not at all 1
A little bit 2
Moderately 3
Quite a bit 4
Extremely 5
These questions are about how you feel and how things have been with you during th e past 4 w eeks. For each question, please
give the one answer tha t comes closest to the way you have been feeling.
How much of the tim e during the past 4 w eeks . . .
(Circle One N um ber on Each Line)

23. Did you feel full of pep?

All of the
Time

Most of
the Time

A Good Bit
of the Time

Some of
the Time

A Little of
the Time

None of
the Time

1

2

3

4

5

6
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24. Have you been a very nervous
person?

1

2

3

4

5

6

25. Have you felt so down in the
dumps that nothing could cheer you
up?

1

2

3

4

5

6

26. Have you felt calm and peaceful?

1

2

3

4

5

6

27. Did you have a lot of energy?

1

2

3

4

5

6

28. Have you felt downhearted and
blue?

1

2

3

4

5

6

29. Did you feel worn out?

1

2

3

4

5

6

30. Have you been a happy person?

1

2

3

4

5

6

31. Did you feel tired?

1

2

3

4

' 5

6

32. During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your
social activities (like visiting with friends, relatives, etc,)?
(Circle One Number)
All of the time 1
Most of the time 2
Some of the time 3
A little of the time 4
None of the time 5
How TRUE or FALSE is each of the following statements for you. (Circle One Number on Each Line)

Definitely
True

Mostly
True

Don't
Know

Mostly
False

Definitely
False

33. I seem to get sick a little easier than other
people

1

2

3

4

5

34. I am as healthy as anybody I know

1

2

3

4

5

35. I expect my health to get worse

1

2

3

4

5

36. My health is excellent

1

2

3

4

5
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Session One. The Diabetes Self-Efficacy Scale (DSES)

We would like to know how confident you are in doing certain activities. For each of the following
questions, please choose the number that corresponds to your confidence that you can do the tasks
regularly at the present time.
1. How confident do you feel that you
can eat your meals every 4 to 5
hours every day, including breakfast
every day?
2. How confident do you feel that you
can follow your diet when you have
to prepare or share food with other
people who do not have diabetes?
3. How confident do you feel that you
can choose the appropriate foods to
eat when you are hungry (for
example, snacks)?
4. How confident do you feel that you
can exercise 15 to 30 minutes, 4 to 5
times a week?
5. How confident do you feel that you
can do something to prevent your
blood sugar level from dropping
when you exercise?
6. How confident do you feel that you
know what to do when your blood
sugar level goes higher or lower than
it should be?
7. How confident do you feel that you
can judge when the changes in your
illness mean you should visit the
doctor?
8.

How confident do you feel that you
can control your diabetes so that it
does not interfere with the things you
want to do?

not at all
confident

|
1

|
2

3

|

|

|

not at all
confident

|
1

|
2

3

not at all
confident

|
1

|
2

|
3

|
4

5

not at all
confident

|
1

|
2

|
3

|
4

5

not at all
confident

|
1

|
2

3

not at all
confident

|
1

|
2

3

4

not at all
confident

|
1

|
2

|
3

4

5

not at all
confident

|
1

|
2

|
3

|
4

5

4

|

|
5

|
9

1

6

|
7

|
8

|
9

1

|
6

|
6

|

|

|

7

|

totally
confident

|

totally
confident

|

[
|
|
8 9 1 0

totally
confident

|

|
|
|
8 9 1 0

totally
confident

|
7

|
8

|
9

1

6

|
7

|
8

|
9

1

|

|
6

|

7

0

|

totally
confident

|

totally
confident

|

|
|
|
8 9 1 0

totally
confident

|

|
|
|
8 9 1 0

totally
confident

7

|
6

0

|

6

|
5

|

7

|

5

|

|
8

|

|
4

|
7

|

4

|

6

5

|
0

|
0
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Session One. The Activities-specific Balance and Confidence scale (AB C scale) (Powell & Myers

1995)

' For each of the following activities, please indicate your level of self-confidence by choosing a
corresponding number from the following rating scale:
0%
10
20
No confidence

30

40

50

60

70

80

90
10 0%
Completely confident

How confident are you that you can maintain your balance and remain steady when you . . ,
1. walk around the house? _____ %
2. walk up or down stairs? ____ _%
3. bend over and pick up a slipper from the front of a closet floor? _____ %
4. reach for a small can off a shelf at eye level? _____ %
5. stand on your tip toes and reach for something above your head? _____ %
6. stand on a chair and reach for something? _____ %
7. sweep the floor? _____ %
8. walk outside the house to a car parked in the driveway? _____ %
9. get into or out of a car? _____ %
10. walk across a parking lot to the mall? _____ %
11. walk up or down a ramp?

____ %

12. walk in a crowded mall where people rapidly walk past you? _____ %
13. are bumped into by people as you walk through the mall? ._____%
14. step on or off an escalator while holding onto a railing? _____ %
15. step on or off an escalator while holding parcels and cannot hold onto the railing? -------%
16. walk outside on icy sidewalks? _____ %

Note. From Powell and Myers (1995), Myers et al. (1996), and Myers et al. (1998). Reprinted
with permission of the Gerontology Society of America. Copyright by the GSA.

Administrating the ABC
The ABC can be self-administered or administered via personal or telephone interview. Use a
larger typeset font for self-administration, while an enlarged version of the rating scale on an
index card w ill facilitate in-person interviews. Instruct respondents, 'If you do not currently
do the activity in question, try to imagine how confident you would be if you had to do the
activity. If you normally use a walking aid or hold onto someone, rate your confidence qs if you
were using these supports. If you have any questions, please ask.'

Instruetionsfor-Scoring
Total the ratings (possible range = 0 to 1,600) and divide by 16 (or the number of items
completed) to get each person's ABC score. If a person qualifies her response to items 2, 9, 11,
14, or 15, solicit separate ratings and use the low est confidence of the two (as this will limit the
entire activity, e.g., likelihood of using stairs). Total scores can be computed if at least 12 of the
16 items are answered and alpha does not decrease appreciably with the deletion of item 16
icy sidewalks—for administration in warmer climates (Myers et ol. T998)._________________

The ABC has good test-retest reliability, high internal consistency, is able to discriminate between
fallers and nonfallers and low versus high mobility groups (Powell and Myers 1995), and
corresponds with balance performance measures (Myers el ol. 1996). ABC scores above 50 and
less than 80 are indicative o f a moderate level of functioning characteristic of persons with
chronic health conditions. Scores above 80 indicate higher functioning, usually active older
adults and are achievable through exercise and rehabilitative therapies (Myers et al. 1998).
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D a y 1. B lo o d A n a ly s is C h e c k lis t: H b A l c testing

SubjectCode
Date

□

Put gloves on

□

W a r m hand to increase blood flow

□

Clean skin with alcohol wipe

□

Prepare lancing device

□

Set up H b A l c holder and chemical, open cap

□

Lance skin

□

Express blood drop and wipe with cotton pad

□

Express blood drop into capillary for H b A l c

□

Fill H b A l c capillary tube to black line (do not squeeze)

□

Squeeze blood into H b A l c chemical tube and squeeze rinse 2-3 times

□

Recap tube and shake vigorously 6-8 times

□

Wipe finger and apply dressing ifneeded

□

Open Pouch 2 of HbAlc, insert cartridge into metre immediately, monitor/code match

□

♦ S M P L appears, fill dropper by squeezing and releasing slowly (leave dropper in tube)

□

Liquid in overflow bubble (never out) squeeze capillary contents only xl onto test spot

□

Results in 5 minutes, alternating signal Q C O K unless error code

Glycosylated Hemoglobin Level (%)

□

R emove cartridge from H b A l c metre and dispose, remove gloves and dispose
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Session One. The Michigan Neuropathy Screening Instrument Questionnaire (M NSI)
Please take a few minutes to answer the questions below about the feeling in your legs and feet.

Circle YES or NO based on how you usually feel.
1.

Are your legs and/or feet n u m b ?

YES

NO

2.

D o you ever have any burning pain in your legs and/or your
feet?

YES

NO

3.

Are your feet too sensitive to touch?

YES

NO

4.

D o you get muscle cramps in your legs and/or feet?

YES

NO

5.

D o you ever have any prickling feelings in your legs or feet?

YES

NO

6.

Does it hurt whe n the bed covers touch your skin?

YES

NO

W h e n you get into the tub or shower, are you able to tell the

YES

NO

8. Have you ever had an open sore on your foot?

YES

NO

9. Has your doctor ever told you that you have diabetic
neuropathy?

YES

NO

10. D o you feel weak all over most of the time?

YES

NO

11. Are your symptoms worse at night?

YES

NO

12. D o your legs hurt w h e n you walk?

YES

NO

13. Are you able to sense your feet whe n you walk?

YES

NO

14. Is the skin on your feet so dry that it cracks open?

YES

NO

15. Have you ever had an amputation?

YES

NO

7.

hot water from the cold water?

Scoring: The greater the number of positive (yes) responses equals the greater the severity of
neuropathy. Tabulate score out of 15, each “yes” response receives one point and “no” receives zero
points (Feldman et al., 1994).
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Session One. Screening for Peripheral Neuropathy - Checklist (per Neuropen Instructions)
Subject Code

o
o
o
o
o

o

Rest subject’s foot on a stable and padded surface (towel on floor). Ensure they are
comfortable and free from distractions
Wipe the tip with an alcohol pad in the presence of the subject
Explain testing procedure by showing them h o w stimulus feels on the back of their hand
Once testing begins, ensure the patient cannot see the test being performed, use a shield or
ask them to look away
Press the monofilament at 90° angle to the skin surface and increase pressure until it bows hold it for 2 seconds. Instruct the subject to say “yes” or “n o w ” wh e n they believe that they
can detect the stimulus. Test sites at random on dorsum of great toe on the non-dominant leg.
Place an x where site of compression is detected. Put an “N ” where no stimulus is sensed.
Repeat test a total of 10 times,
Wipe tip of pen with alcohol after end of test. Replace a tip and discard in sharps container
after ten trials (100 uses). D O N O T U S E N E A R B R O K E N S K I N / O P E N SORES. IF THIS
C A N N O T B E A V O I D E D , U S E A N E W TIP A N D D I S C A R D A F T E R U S E IN S H A R P S
CONTAINER.

RIGHT

LEFT

p
P

l \
SCORE
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_____ /10

Appendix D. Balance, Functional Mobility and Performance Scoring

Session One, Berg Balance Scale (BBS)

ITEM

DESCRIPTION

S C O R E (0-4)

1.

Sitting to standing_______________________ _____

2.

Standing unsupported

_____

3.

Sitting unsupported

_____

4

Standing to sitting

_____

5.
6.

Transfers
Standing with eyes closed

_____
_____

7.

Standing with feet together

_____

8.

Reaching forward with outstretched arm

_____

9.

Retrieving object from floor

_____

10.

Turning to look behind___________________ _____

11.

Turning 360 degrees_____________________ _____

12.

Placing alternate foot on stool_____________ _____

13.
14.

Standing with one foot in front

______

Standing on one foot_____________________ _____

TO TAL

_____

*references on page 4

GENERAL INSTRUCTIONS
Please demonstrate each task and/or give instructions as written. W h e n scoring, please record
the lowest response category that applies for each item.
In most items, the subject is asked to maintain a given position for specific time.

Progressively

more points are deducted if the time or distance requirements are not met, if the subject's
performance warrants supervision, or if the subject touches an external support or receives
assistance from the examiner.

Subjects should Understand that they must maintain their balance

while attempting the tasks. T h e choices of which leg to stand on or h o w far to reach are left to
the subject. Poor judgment will adversely influence the performance and the scoring.
Equipment required for testing are a stopwatch or watch with a second hand, and a ruler or other
indicator of 2, 5 and 10 inches (5, 12.5 and 25 cm). Chairs used during testing should be of
reasonable height. Either a step or a stool (of average step height) m a y be used for item # 12.

116

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

SITTINGTOSTANDING
INSTRUCTIONS: Pleasestandup. Trynottouseyourhandsforsupport.
(

(
(
(
(
2.

abletostandwithout usinghandsandstabilizeindependently
) 3abletostandindependentlyusinghands
) 2abletostandusinghandsafterseveral tries
) Ineedsminimal aidtostandortostabilize
) 0needsmoderateor maximal assisttostand
) 4

STANDINGUNSUPPORTED
INSTRUCTIONS: Pleasestandfortwominuteswithout holding.
(
(
(
(
(

abletostandsafely2minutes
) 3abletostand2minuteswithsupervision
) 2abletostand30secondsunsupported
) Ineedsseveral triestostand30secondsunsupported
) 0unabletostand30secondsunassisted

) 4

I f a subject is able to stand 2 minutes unsupported, score fu ll points fo r sitting unsupported. Proceed to item #4.

3.

SITTINGWITH BACKUNSUPPORTEDBUTFEETSUPPORTEDONFLOORORONA
STOOL
INSTRUCTIONS: Pleasesit witharmsfoldedfor2minutes.
(
(
(
(
(

4.

)4 abletosit safelyandsecurely2minutes
)3 abletosit 2minutesundersupervision
>2 abletosit 30seconds
)1 abletosit 10seconds
)0 unabletositwithout support 10seconds

STANDINGTOSITTING
INSTRUCTIONS: Pleasesit down.
(
) 4 sitssafelyw
ithminimal useofhands
( ) 3 controlsdescentbyusinghands
( ) 2 usesbackoflegsagainstchairtocontrol descent
( ) 1 sitsindependentlybut hasuncontrolleddescent
( ) 0 needsassistancetosit

5.

TRANSFERS
INSTRUCTIONS: Arrangechairs(s) forapivot transfer. Asksubject totransfer onewaytowardaseat
witharmrestsandonewaytowardaseat without armrests. Youmayusetwochairs(onewithandone
without armrests) orabedandaChair.
(
(
(
(
(

)4

)3
)2
)1
)0

abletotransfersafelywithminoruseofhands
abletotransfersafelydefiniteneedofhands
abletotransferwithverbal cueingand/orsupervision
needsonepersontoassist
needstwopeopletoassistor supervisetobesafe
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6

STANDING UNSUPPORTEDWITH EYESCLOSED
INSTRUCTIONS: Pleasecloseyoureyesandstandstill for 10seconds.
(
(
(
(
(

7.

abletoplacefeet together independentlyandstand1minutesafely
abletoplacefeet together independentlyandstandfor 1minutewithsupervision
abletoplacefeet together independentlyandtoholdfor30seconds
needshelptoattainpositionbut abletostand15secondsfeet together
needshelptoattainpositionandunabletoholdfor 15seconds

)4
)3
)2
)1
)0

canreachforwardconfidently>25cm(10 inches)
canreachforward>12.5 cmsafely(5 inches)
canreachforward>5 cmsafely(2 inches)
reachesforwardbut needssupervision
losesbalancewhiletrying/ requiresexternal support

PICK UPOBJECT FROMTHE FLOORFROMASTANDING POSITION
INSTRUCTIONS: Pickuptheshoe/slipperwhichisplacedinfront ofyourfeet.
(
(
(
(
(

10.

)4
)3
)2
)1
)0

REACHING FORWARDWITH OUTSTRETCHEDARMWHILE STANDING
INSTRUCTIONS: Lift armto90degrees. Stretchoutyour fingersandreachforwardasfarasyou
can. (Examiner placesaruleratendoffingertipswhenarmisat90degrees. Fingersshouldnottouch
therulerwhilereachingforward. Therecordedmeasureisthedistanceforwardthatthefingerreach
whilethesubject isinthemost forwardleanposition. Whenpossible, asksubject tousebotharms
whenreachingtoavoidrotationofthetrunk.)
(
(
(
(
(

9

abletostand 10secondssafely
abletostand 10secondswithsupervision
abletostand 3seconds
unabletokeepeyesclosed3seconds but stayssteady
needshelptokeepfromfalling

STANDING UNSUPPORTEDWITH FEETTOGETHER
INSTRUCTIONS: Placeyourfeet togetherandstandwithout holding.
(
(
(
(
(

8

)4
)3
)2
)1
)0

) 4

)3
)2
)1
)0

abletopickupslippersafelyandeasily
abletopickupslipperbut needssupervision
unabletopickupbut reaches2-5cm(1-2 inches) fromslipperandkeepsbalanceindependently
unabletopickupandneedssupervisionwhiletrying
unabletotry/needsassist tokeepfromlosingbalanceor falling

TURNINGTO LOOK BEHINDOVERLEFTANDRIGHT SHOULDERSWHILE STANDING
INSTRUCTIONS: Turntolookdirectlybehindyouovertowardleft shoulder. Repeat totheright.
Examinermaypickanobject tolookat directlybehindthesubject toencourageabettertwist turn.
(
) 4 looks behind fromb
othsidesandweight shiftswell
( ) 3 looksbehindonesideonlyothersideshowslessweight shift
( ) 2 turnssidewaysonlybut maintainsbalance
( ) 1 needssupervisionwhenturning
( ) 0 needsassist tokeepfromlosingbalanceorfalling
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11.

TURN 360 DEGREES
INSTRUCTIONS: Turn completely around in a full circle. Pause. Then turn a full circle in the other
direction.
( ) 4 able to turn 360 degrees safely in 4 seconds or less
( ) 3 able to turn 360 degrees safely one side only in 4 seconds or less
( )2
able to turn 360 degrees safely but slowly
( ) 1 needs close supervision or verbal cueing
( ) 0 needs assistance while turning

12.PLACING ALTERNATE FOOT ON STEP OR STOOL WHILE STANDING UNSUPPORTED
INSTRUCTIONS: Place each foot alternately on the step/stool. Continue until each foot has touched
the step/stool four times.
( ) 4 able to stand independently and safely and complete 8 steps in 20 seconds
( ) 3 able to stand independently and complete 8 steps >20 seconds
( ) 2 able to complete 4 steps without aid with supervision
( ) 1 able to complete >2 steps needs minimal assist
( )0
needs assistance to keep from falling/unable to try
13.

STANDING UNSUPPORTED ONE FOOT IN FRONT
INSTRUCTIONS: (DEMONSTRATE TO SUBJECT)
Place one foot directly in front o f the other. If you feel that you cannot place your foot directly in front, try
to step far enough ahead that the heel o f your forward foot is ahead of the toes of the other foot. (To score 3 points,
the length of the step should exceed the length o f the other foot and the width of the stance should approximate the
subject's normal stride width)
( ) 4 able to place foot tandem independently and hold 30 seconds
( ) 3 able to place foot ahead o f other independently and hold 30 seconds
( ) 2 able to take small step independently and hold 30 seconds
( ) 1 needs help to step but can hold 15 seconds
( )0
loses balance while stepping or standing
14.

STANDING ON ONE LEG
INSTRUCTIONS: Stand on one leg as long as you can without holding.
( )4 able to lift leg independently and hold >10 seconds
( )3 able to lift leg independently and hold 5-10 seconds
( ) 2 able to lift leg independently and hold = or >3 seconds
( ) 1 tries to lift leg unable to hold 3 seconds but remains standing independently
( )0
unable to try or needs assist to prevent fall
(

)

TOTAL SCORE (Maximum = 56)
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Session One. Physical Performance Score Sheets
Subject Code

1.

Timed “u p a n d go’* test ( T U G )

The T U G test involves measurement of the time (seconds) that it takes for a person to stand
up from an arm chair (approximately 45 c m high) after “go”, walk a straight distance of 3 m at a
comfortable or regular pace, turn, walk back to the chair and sit d o w n again (Figure 3).
Practice Trial (not timed)
Time to complete task

s

* Regular footwear is worn, using any ambulatory aids that s/he normally uses, without any other
sort of physical assistance. The person begins the test with her/his back against the chair with any
ambulatory aids available in hand. A fust try is given in order to familiarize the subject with the
protocol (Podsiadlo & Richardson, 1991).

PIVOT

<*

►

Time (s) to get up, walk to pivot point, pivot, walk back to chair and sit d o w n

3 metres between chair and pivot point, one-way

X
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Subject Code

2. The 4-metre timed walk.
The subject will be asked to walk in a 4 m pathway. At the start, each subject will be required
to stand with both feet touching the start line, and commence walking at a normal, comfortable speed
at the instruction “go”. The time it takes for the individual to walk 1 m from the start and 4 m from
start will be recorded (Figure 6). This protocol will be repeated 3 times (2 times per usual pace and 1
time at the fastest walking pace). The speed of the faster usual pace walks will be recorded. To
calculate average walking speed, 4 m or l m divided by time to complete the task (seconds). Regular
footwear is worn, using any walking aids that s/he normally uses, without any other sort of physical
assistance (Guralnik et al., 1995).
Usual Pace:
Time to walk l m _________________________ s

Walking Speed_______________________ m/s

Time to walk 4 m

s

Walking Speed_______________________ m/s

_______________ s
s

Walking Speed_______________________ m/s
___________ m/s
Walking Speed

Fastest Pace:
Time to walk l m _________________________ s
Time to walk 4 m _________________________ s

Walking Speed_______________________ m/s
Walking Speed_______________________ m/s

____________

Usual Pace:
Time to walk l m
Time to walk 4 m

1 metre

3 metres

3

Time (s) to complete 1 m o f task

Total time (s) to complete task
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Subject Code

3. Step Test Exercise Prediction o f VO* max (STEP)
T w o 20 c m steps will be used for stepping up (both feet on top of step) and d o w n (both feet at
bottom of step) 20 times at three difference paces (Figure 5), Resting heart rate will be measured
before die onset of the tests. In the first part (familiarization component), the subject will be asked to
step up and do w n 10 step cycles at a pace considered by the subject to be “slow”. After 5 minutes of
rest, the subject will be asked to repeat the step protocol, but using 20 step cycles instead of 10 step
cycles at a “normal” pace (timed in seconds) and post-exercise heart rate will also be recorded
immediately as well as their R P E (Table 2). After another 5 minute rest period or after the heart rate
returns to within 5 beats per minute (BPM) of the resting heart rate, file subject will be asked to
repeat the procedure (20 steps cycles) but at a “fast” pace (timed in seconds) and post-exercise heart
rate will also be recorded (Table 2). Step test speed, heart rate reserve, oxygen cost of stepping and
oxygen pulse will be calculated (Table 3) andVOj m a x will be estimated for males and females
(Table 4) (Petrella et al., 2001).
Resting Heart Rate _____
Step Task Rate
Normal
bast
Step Task Rate
Normal

BPM

T i m e to Complete Task (s)
T1
T2

Post-Exercise Heart Rate ( B P M )
SHRi
sh r

T i m e to Complete Task (s)

2

Post-Exercise Heart Rate ( B P M )

RPE
6-20
6-20
RPE

Fast

2& cm

122

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix E. Scientific Journal Manuscript
Gender and Physical Activity: Necessary Measures when Assessing Strength in Persons
with Type 2 Diabetes
Lynette Singh-Peters BSc 1 Gareth R. Jones PhD2, Kenji A. Kenno PhD1, Jennifer M. Jakobi
PhD 1
1)
2)

Department of Kinesiology, Faculty of Human Kinetics, University of
Windsor, Windsor, ON., N9B 3P4
School of Occupational Therapy, Faculty of Health Sciences, University of
Western Ontario, London, ON., N6 G 1H1

Corresponding Author:
Jennifer M. Jakobi PhD
University of Windsor
Faculty of Human Kinetics
Department of Kinesiology
Human Kinetics Bldg., Rm. 120
Telephone: 519-253-3000 ext.2473
Facsimile: 519-973-7056
Email: jjakobi@uwindsor.ca

Acknowledgements: Mr. Don Clarke is thanked for his contributions to the mechanical and
technical design and build of the isometric dynamometer and strain gauge. W e also
acknowledge product donations and financial support from Bayer Incorporated, Canus
Canada, Company’s Coming Publishers, Kerr Brothers Ltd., and Pfizer Canada, University
of Windsor Women’s Research Grant.

Word Count: 4,429 (including references)
Running Title: Gender, Activity and Strength

123

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

OBJECTIVE Assess the role of muscle strength on functional mobility when physical activity is matched
in addition to weight, gender, and age in persons with type

2

diabetes.

METHOD Physical activity was assessed and (N=14) matched between persons with type 2 diabetes
and non-diabetic controls.

Performance tests were conducted and isometric muscle

properties and strength measured.

RESULTS Physical activity was similar (p=0.83) but H bA lc was significantly elevated in the type 2
diabetes group (8.4 + 1.3 %) compared with controls (6.1 + 0.4 %). Contractile properties
(p=0.66) and strength were similar between groups (p=0.19). When gender and physical
activity were considered independent factors vigorous activity accounted for 25 % of muscle
strength and functional mobility scores were no lower in persons with type

2

diabetes.

CONCLUSION Hyperglycaemia does not cause muscle weakness and subsequent declines in function in
persons with type 2 diabetes. Daily activity may maintain muscle strength, but exercise is
needed to lower hyperglycaemia and preserve mobility.

KEYWORDS Physical activity, exercise, functional mobility, strength, gender
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In tro d u c tio n Deterioration of functional mobility is estimated to be 2 to 3 times higher in persons with
diabetes compared to individuals without (1-3), and this decline is exacerbated in women
(4).

The association between muscle weakness and decline of functional mobility in

persons with type

2

diabetes is questionable because most studies do not quantify muscle

strength; rather manual muscle testing or subjective questionnaire assessments have been
utilized.

In addition, there is substantial literature to suggest that women are generally

weaker than men (5) and that exercise training increases muscle strength resulting in
higher functional mobility scores (6 ), but this knowledge is generally not applied to studies
of persons with type 2 diabetes.

In order to clearly ascertain whether muscle weakness

influences functional mobility in persons with type

2

diabetes, gender and physical activity

(PA) must be considered independent factors, and strength quantified in individuals without
co-morbidities associated with hyperglycaemia. Co-morbidities such as neuropathies, foot
ulcerations, retinopathy and nephropathy are also autonomous factors that influence
muscle strength and thus these

conditions should

be excluded from

independent

assessment of PA on strength and muscle function. In this study we have weight-, age-,
gender- and activity-matched persons with type

2

diabetes to non-diabetic control subjects

to determine whether muscle strength is altered with chronic hyperglycaemia in a manner
that impairs functional mobility.
M e th o d s -

Subjects, Diabetes and Physical Activity Assessments
Prior to participation all subjects provided written informed consent.

Persons with type 2

diabetes were recruited from the local university area; all were independent community
dwelling adults. A local diabetes education group, posters (-7 5 ), community newspaper
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(distribution rate; 207,163), and mass campus email to staff and faculty (2,339 distribution
list) were utilized for subject recruitment. The majority of respondents (n=20) were from the
campus email advertisements, whereas the fewest responses came through diabetes
educators (n=1). Control subjects were recruited similarly and matched with extreme care
to persons with diabetes (Table 1).

Initially subjects were screened with the self-report

Yale Physical Activity Survey (7) and excluded based upon contraindications of the study
(physician

diagnosed

diabetic

neuropathies,

bone

spurs,

fibromyalgia,

cardiac

complications). Consequent to a possible match objective physical performance tests were
conducted. The sample consisted of 14 persons with type
10

2

diabetes (n = 6 $, n= 8 S) where

(n = 6 $, n=4 S) were successfully matched to control subjects. Three male persons with

type 2 diabetes were unmatched because of high weight or low activity scores (128.9 ± 8.3
kg, 3-4x less) and the fourth male subject was excluded due to extensive participation in
planned exercise training (3x higher than other scores).

The RAND 36-item Health Survey 1.0 [SF-36] was utilized to assess physical functioning,
bodily pain, role limitations from health problems, and role limitations from emotional or
personal issues, emotional well-being, social functioning, energy/fatigue and perception of
general health. The Diabetes Self-Efficacy Scale [DSES] was employed to yield information
about personal confidence with respect to living and caring for diabetes ( 8 ). The Activitiesspecific Balance and Confidence scale [ABC] (9) assessed balance confidence performing
daily activities.

A series of physical performance tests were utilized to quantify functional

mobility and balance, including the Berg Balance Scale [BBS] (10), and the Timed “up and
go” test [TUG] (11). The Step Test Exercise Prediction (STEP) was employed to measure
heart rate responses to exercise, and to estimate submaximal oxygen uptake ( 1 2 ).
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Sensory threshold was assessed using a 10- Semmes-Weinstein monofilament (Neuropen,
Owen Mumford Ltd., UK) by application of the filament to the dorsum of each great toe (13).
In conjunction with this test the Michigan Neuropathy Screening Instrument [MNSI] was
also utilized to assess the existence of peripheral neuropathy (14).

Control subjects were

also tested to maintain consistency between groups and to assess non-diabetic related
sensory abnormalities.

Muscle Properties
Voluntary strength and electrically induced contractile properties were assessed in the
tibialis anterior.

This muscle is the primary dorsi-flexor (raising forefoot and toes) and is

closely associated with deterioration of gait (15).

All tests were performed on the non

dominant leg except in three instances where knee joint surgery (n= 2 ) or previous muscle
injury (n=1) precluded investigation.

The subject was seated in a custom-built isometric

dynamometer with the ankle at 30° of plantar flexion, and the hip and knee joints positioned
at 90°. The commercial load cell was fixed to the underside of the metal footplate (Model
MLP-500-T, Transducer Techniques, Inc., Temecula, CA). Signals from the load cell were
amplified (1000x) filtered (60-Hz notch filter), and sampled at 1000 Hz (Model V72-25A,
Coulbourn Instruments, Allentown, PA) and subsequently analog to digital converted with
offline quantification (Spike 2, Cambridge Electronic Design Ltd., Cambridge, UK).

Contractile properties w e re elicited percutaneously using an electrical stim ulator (D S 7 A H ,

Digitimer Ltd., Hertfordshire, UK) and a hand-held custom-made electrode bar (4 cm
length). The peroneal nerve was palpated along the lateral side of the patello-femoral joint.
Pulse intensity was determined by slow increases in current until a plateau in twitch force
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was obtained. Ten maximal electrical pulses (100ps) at a frequency of 1 Hz were applied
and the peak torque (PT), time to peak torque (TPT) and half relaxation time (HRT)
determined from an average of 8-10 responses. To assess maximal voluntary contraction
(MVC) subjects were instructed to lift their forefoot upward as hard and as fast as possible
and maintain the position for 5 seconds while provided with visual feedback from an
oscilloscope and strong verbal encouragement. To familiarize subjects with the MVC 3-5
practise attempts were given prior to testing.

Following the practice trials 3 ‘test’

contractions were performed and the highest attempt was utilized in the analysis. In order
to verify that the force produced was maximal the twitch interpolation technique was utilized
which involves application of a maximal electrical stimulus over the peroneal nerve during
and after the MVC. The presence of a superimposed twitch on the force record indicates a
lack of motivation or central failure. This measure is quantified by expressing the difference
in amplitude of the interpolated twitch response to the post MVC twitch response as a
percentage of the latter (16,17).

A two-way analysis of variance (gender x diabetic condition) was utilized to determine
differences in muscle strength, PA, health and well-being between persons with type 2
diabetes and controls.

All values are reported as the mean + standard deviation.

Significance set at p < 0.05.

Results Subjects, Diabetes and Physical Activity A ssessm ents
Physical activity was successfully matched between the two groups with the questionnaire,
but glucose at the time of testing and H bA lc were significantly greater in persons with type
2 diabetes (Table 1). The average duration of physician diagnosed diabetes was 5.2 ± 4.4
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years.

As the primary means to manage hyperglycaemia 7 subjects were utilizing oral

hypoglycaemic agents, two insulin and one diet manipulations. All persons with diabetes
indicated that they were aware of the benefits of exercise in managing diabetes, but all
subjects reported that they did little exercise and all considered themselves overweight.

The neuropathy scores, as assessed with the MNSI and monofilament scores did not differ
between groups (Table 2). Results from the RAND SF-36 questionnaire indicated that
persons with type

2

diabetes perceived their health to be worse compared to the non

diabetic control group, specifically

how poor emotional and physical health (p=0.004 -

0.02) had affected their social life (family, work, friends) (Figure 1). This is the first study to
measure muscle properties and match PA between groups, and when activity is accounted
for functional performance measures did not differ for fear of falling (ABC), balance (BBS),
mobility (TUG) and stair climbing time (STEP). Moreover, assessment of resting heart rate
and its responses to an exercise stair challenge and the subsequent prediction of submaximal oxygen consumption (VO 2 ), an indicator of cardiorespiratory fitness, was also
similar between groups (Table 2).

Muscle Properties
Electrically induced contractile properties were similar between groups (Table 3). Voluntary
strength also did not differ between persons with diabetes and controls (p=0.19) and
maximal activation was achieved in both the diabetes (98.8 + 3.3 %) and control groups
(99.0 +

1 .0

%) (p=0.25).

However, there was an effect of gender for voluntary strength.

Men were significantly stronger (40.5 + 2.1 Nm) compared with women (30.3 + 1.7 Nm)
irrespective of the condition of diabetes. As vigorous activity increased, irrespective of
gender and diabetic condition, muscle strength also increased (r2 = 0.25).
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Discussion This study clearly indicates that muscle strength and functional mobility are not altered
when co-morbidities are not apparent in persons with type

2

diabetes, and when age-,

gender-, and PA level are matched to non-diabetic controls muscle strength and functional
mobility are not altered

as a result of hyperglycaemia.

As well,

irrespective of

hyperglycaemia the higher the PA scores the greater the muscle strength.
suggest that reductions in functional mobility in persons with type
from muscle weakness.

2

These data

diabetes do not result

Rather, chronic elevation of blood glucose, indicative in this

sample by elevated HbA1c (8.4 %), likely results in co-morbidities that inevitably influence
muscle strength and in-turn result in declines in independent function.

Results also

demonstrate the necessity in delineating between genders and defining the activity
characteristics of both the diabetic and non-diabetic control groups. When gender and PA
are considered as independent factors women were weaker than men irrespective of the
diabetic condition, and 25 % of muscle strength was accounted for by increased
participation in vigorous PA.
persons with type

2

Thus, PA is a key component to maintaining strength in

diabetes, and must be considered when evaluating weakness and

functional decline in this condition. Longitudinal studies monitoring PA, glucose control and
co-morbidities associated with type

2

diabetes are warranted in order to fully ascertain

additional sources that contribute to altering muscle strength and in-turn functional mobility.
This study also alludes to the necessity of behaviour modification studies in determining
possible ways to increase the intensity of PA or participation in exercise programs into the
lifestyle patterns of persons with type 2 diabetes.

It seems that persons with type 2
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diabetes are aware of the importance of exercise, but do not utilize this knowledge as a
method of glucose control.

PA refers to bodily movement produced by the contraction of skeletal muscle that requires
energy expenditure in excess of resting energy expenditure.

Whereas, exercise is

identified as a subset of PA that is planned and structured and involves repetitive bodily
movement

to

improve

or

maintain

any

of

(cardiorespiratory, muscular and flexibility) (18).

the

components

of

physical

fitness

Thus, in this study individuals that

establish and adhere to a planned exercise program were excluded, and daily PA was
scored and matched between persons with type 2 diabetes and controls. There is strong
and consistent evidence that exercise training is beneficial to persons with type

2

diabetes

(19-21) and this study confirms that persons with type 2 diabetes are aware of the
importance of exercise but do not utilize this knowledge with structured participation. The
activity scores are indicative of modest levels of daily PA, and self-report revealed that
walking was the primary activity of choice. It has been shown that home based training is
sufficient to maintain strength gains subsequent to a structured and group based exercise
program, but it was suggested that the intensity declined to a level that resulted in minimal
influence on glucose control (22).
persons with and without type

2

In this study, PA levels where matched between

diabetes and when this is undertaken lower leg strength is

similar between groups. However, light activity did not aid in controlling hyperglycaemia in
persons with type

2

diabetes and it is likely that moderate to heavy intensity PA and/or

structured exercise would aid in glucose management (23, 24).

Thus, practitioners must

acknowledge and promote that daily PA aids in maintaining strength to a level that is similar
to controls, but more moderate to vigorous PA, such as participation in a structured
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exercise regime is necessary to aid in glucose control and inevitably delay co-morbidities
associated with type

2

diabetes.

Blood glucose and glycosylated haemoglobin were ~40 % higher in the diabetic group
compared with the control. The level of glucose control in the diabetic group was within the
5.0 - 10.0 mmol/L range that is broadly advised, however the glycosylated haemoglobin
score was slightly elevated (8.4 %), based upon the <7 % suggested by The Canadian
Diabetes Association (25). Subjects should attempt to consistently lower blood glucose and
for longer time periods because elevated HbA1c levels are associated with an increased
risk of both microvascular and macrovascular complications, (26-29), and hyperglycaemia
is strongly associated with undetected motor neuropathies (30,31). It is likely that over time
neuropathies, rather than hyperglycaemia, result in muscle weakness and that the
inevitable decline in function may be misattributed to a loss of strength.

The dorsi-flexors were chosen because they are functionally relevant to gait and balance
ability (15, 32, 33) and typically demonstrate early signs of sensory and motor weakness
relative to the thigh, arm and wrist (30,34). Very few studies have utilized isometric muscle
strength as a means of determining strength; rather most studies utilize manual muscle
testing or clinical grading and few studies have utilized isokinetic strength (30,31). Isokinetic
measures of strength provide a quantifiable measure of dynamic muscle torque, however
this type of testing requires expensive equipment and the resultant torque is dependent
upon the speed of the contraction (35, 36) and training or familiarization with the contraction
is necessary because of the unique nature of the movement (37).

Isometric measures of

force are readily quantified, require minimal equipment with negligible costs, are relatively
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easy to learn and perform (17, 38) and it is well established that maximal force can be
obtained and the maximal level of activation ensured with the twitch interpolation technique
(17). With sufficient practise the ability to fully activate muscle and attain MVC is generally
observed in a variety of conditions (17,38,39). Thus, isometric force is not only a viable
means to assess muscle strength, but application of the twitch interpolation technique
shows that individuals with type

2

diabetes were able to fully activate the tibialis anterior.

These results indicate that the diabetic condition does not preclude maximal force

production and that when maximal activation is attained muscle strength is similar to age-,
gender-, PA matched controls.

Contractile properties were also similar between groups. There is substantial literature to
indicate that in rodent models of streptozotocin induced diabetes there are alterations in
electrically induced contractile properties (40-42), yet no information is available in persons
with type 2 diabetes. There is no indication of contractile slowing in this study of middleaged persons with type

2

diabetes, and the tension values are within the natural age-

related decline for men and women (43, 44). Our human muscle data, unlike many animal
models indicate that contractile alterations do not occur in the tibialis anterior of persons
with type

2

diabetes who present with no diagnosed or overt neuropathies.

Women experience a greater number of years in a state of functional dependence as
compared to men, and this has been associated with loss of muscle mass (45), and it
seems that this relationship is exacerbated in women with type 2 diabetes (46). This study
and many others indicate that women are generally weaker than men (5) and thus it is
imperative to consider gender as an independent factor when assessing strength.
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Many

studies that utilize manual muscle testing fail to consider normal variations in strength due
to this factor as well as age, weight and height (47). When force was normalized to body
weight in this study women and men with type

2

diabetes did not differ from controls,

suggesting that the greater decline in functional mobility in women with type

2

diabetes

does not result from muscle weakness or activation failure. In order to resolve the gender
issue longitudinal studies are necessary and consideration of the onset of co-morbidities in
men and women and their associated alterations upon strength must also be taken into
account.

These data clearly indicate that when daily PA is matched between persons with type 2
diabetes and non-diabetic controls and gender is delineated, muscle strength does not
differ suggesting that it is not lower leg weakness that influences the deterioration of
functional mobility in persons with type

2

diabetes but rather it is more likely associated with

chronic hyperglycaemia and other associated co-morbidities.

Thus, to maintain and/or

improve functional mobility exercise prescription for persons with type

2

diabetes must be of

sufficient intensity (moderate-vigorous) to reduce/control hyperglycaemia and other co
morbidities.

This study visibly addresses the necessity of conducting a prospective

population-based control study evaluating the progressive development of neuropathy in
relation to participation in PA and hyperglycaemia, where gender is assessed as an
independent factor in the relationship between muscle strength and functional mobility in
persons with type

2

diabetes.
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Tables -

Table 1. Anthropometric data of persons with Type 2 diabetes and control individuals.
Values = mean ± SD.

Age (years)
Weight (kg)

Height (cm)

YPAS
(hours/week)
Vigorous Activity
Score
Leisure Index
Score
Moving Index
Score
Glucose (mmol/L)
at time of
strength test
HbA1c (%)

Type 2 Diabetes

Control

p value

52.6 ±6.2
(50.5 + 5.5 2 , 54.5 + 6.0 6')
1 0 2 . 0 ±18.6
(93.3 + 16.2 ?, 97.8 + 8 . 8

51.7 ±6.9
(49.5 + 7.6 ?, 55.0 + 4.7 <$)
99.2 ±18.7
(103.4 + 21.9 2 , 92.9 + 12.7

0.73

S)
172.6 ±12.0
(161.5 + 6.9 ?, 175.3 + 3.8
6)
28.8 +_20.3

6')
170.4 ±6.3
(167.5 + 4.9 2, 174.8 + 6.0(2)

0.60

20.3 +.27.3

0.83

11.5 + 12.03

1 9 .5 + 1 6 .7

0.23

16.4 + 15.1

13.2 + 9.2

0.57

8 .7 + 2.9

9 .0 + 4.0

0.85

8.33 ±2.21

5.50 ±0.95

0 .0 0 1

8.4 ±1.3

6.1 ±0.4

0.0000

n= 0

n= 0

0.72

2

Foot Ulcers
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n/a

Table 2. Functional mobility, balance and daily activity scores. Values = mean ± SD.

DSES
MNSI (%)
Monofilament
Score (/10)
Berg Balance
Scale (%)
TUG (s)
Stair Time (s)
Resting heart rate
(BPM)
Post-Exercise HR
(BPM)
Normal Pace
Fast Pace
Predicted
Submaximal V02
(ml/kg/min)
Normal Pace
Fast Pace

Type 2 diabetes
6 . 8 ±2.3
30.3 ±12.1
9.8 ±0.4

Control
n/a
25.2 ±13.2
9.9 ±0.17

p value
n/a
0.62
0 .2 1

94.8 ±3.3

97.6 ±2.0

0.14

9.5 ±2.2
85.1 ±14.0
72.2 ±9.2

8 .8

±1.3
80.4 ±28.8
69.9 ±9.4

0.37
0.69
0.93

117.2 ±13.9
126.0 ±15.8

120.5 ±18.8
135.7 ±23.3

0.73
0.40

25.3 ±4.4
31.1 ±5.1

27.4 ±6.1
33.2 ±2.4

0.37
0.27
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Table 3. Voluntary and involuntary force results for persons with T2D compared to matched
controls. Values = mean ± SD.

Twitch Contractile
Properties
Peak Torque (Nm)
Time to Peak Torque
(ms)
Half-relaxation time
(ms)
MVC
Peak Torque (Nm)

T2D

Control

p value

4.1 ±1.5
9 4 .8 ± 1 1 .3
114.5 ±22.9

3.9 ±1.3
1 0 0.3113.0
105.8 ±20.0

0 .6 6

39.6 ±9.6

34.3 ±7.6

0.19

0.36
0.49
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Figure Legends Figure 1: Health related questionnaire scores, as assessed with the SF-36. Persons
with type 2 diabetes differed from controls (p<0.05) for all variables. Values are
means + SD.
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